{"title": "PDF", "author": "PDF", "url": "https://iris.paho.org/bitstream/handle/10665.2/787/9789275329399.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Babesiosis .................................................................................58 Leishmaniasis Malaria x 1000 9000 8000 7000 6000 5000 4000 3000 2000 1000 02000 2001 2002 2003 2004 2005 N\u00famero de donaciones voluntarias anuales x 1000 2000 2001 2002 2003 2004 2005 3000 2500 2000 1500 1000 500 0Aunque la proporci\u00f3n de unidades de increment\u00f3 de 15% e n 2001 a 34% e n 2002, se mantuvo sin cam bios el per\u00edodo de 2002 a 2005. Los cuadros 1 y 2 los en los pa\u00edses de h abla no h ispana del Ca ribe PA\u00cdS 2002 2003 2004 2005 Anguila No informado 0 10 10 Antigua y Barbuda 66 12 No informado Aruba 100 100 100 100 Bahamas 10 16 24 15 Barbados No informado No informado No informado No informado Caim\u00e1n 98 99.6 100 100 Curacao 100 100 100 100 Dominica 5 No informado 45 Granada 30 39 35 30 Guyana 16 22 19 22 Hait\u00ed 555 15 Jamaica 10 12 11 10 Montserrat 000 No informado San Kitts y Nevis 18 363 Santa Lucia 69 79 83 82 San Vicente y Granadinas 7 12 15 13 Suriname 100 100 100 100 Trinidad y Tobago 17 No informado No informado 13 Islas Turcas informado 2 Proporci\u00f3n de donaciones voluntarias (%) 2000 2001 2002 2003 2004 2005 40 35 30 25 20 15 10 50CCuuaaddrroo 22 Proporci\u00f3n (%) d e donant es voluntar ios en pa\u00edses de Lat inoam\u00e9r ica PA\u00cdS 2002 2003 2004 2005 Argentina 6878 Bolivia 24 16 23 28 Brasil 47 51 46 53 Chile 2679 Colombia 41 42 50 58 Costa Rica 48 49 57 59 Cuba 100 100 100 100 Rep\u00fablica Dominicana 17 18 20 20 Ecuador 41 30 29 No informado El Salvador 10 10 11 10 Guatemala 4421 Honduras 22 19 16 15 M\u00e9xico 3444 Nicaragua 56 45 42 44 Panam\u00e1 2223 Paraguay 166 10 Per\u00fa 6545 Uruguay 35 32 26 26 Venezuela 11 477 Se estima, en base a la informaci\u00f3n de 28 pa\u00edses del Caribe y Latinoam\u00e9rica se realiza a los donantes requiere un promedio de 15 un riesgo la suministro d e sangre, se una p\u00e9rdida US$ millones en insumos utilizados y estudios socio-antropol\u00f3gicos llevados a cabo de las y y el ambiente de l as instalaciones en las que los donantes sangre SEGURIDAD DE LAS TRANSFUSIONES EN LAS AM\u00c9RICAS (5), presentado por la Directora Organizaci\u00f3n tes alcance establezca una red de voluntarios dispuestos reunido el octubre de 2008, adopt\u00f3 la r esoluci\u00f3n CD48.R7 (24) en la que los Estados Miembros a que: a. que tome a su cargo la planicaci\u00f3n, supervision y el funcionamiento ecaz general educar la comunidad, donaci\u00f3n de sangre remunerada y de reposici\u00f3n para nes del c. Pongan n a la reposici\u00f3n obligatoria de sangre por parte paciente Educaci\u00f3n de donantes potenciales enfoque que donantes de e n que actualmente obtiene la sangre por parte de los Sistemas Nacionales de Sangre de la mayor\u00eda de los pa\u00edses caracter\u00edsticas culturales. por lo tanto, semanales de y proveer el liderazgo de la comunidad en personal de los Servicios de Donantes comunitarios , de apoyarlos la necesidades de la comunidad, los procesos y procedimientos que se llevar\u00e1n a la al propiamente los virus de la inmunodeciencia humana (VIH), de la hepatitis B (VHB), de la hepatitis C (VHC), linfotr\u00f3pico de (HTLV I/II), y la incluir: formas tores y a la como p\u00fablico detectado la donaci\u00f3n o mediante los an\u00e1lisis de laboratorio de la sangre, sea informado al don ante. Los servicios de sangre de ben referir a los donantes sangre sea considerada donaciones y, lo n y salud los candidatos previo a la de (55). El selecci\u00f3n comienza el con sentimiento informado y a la educaci\u00f3n selecci\u00f3n los de con un nivel de detalle que permitir\u00e1 su comprensi\u00f3n al personal de los servicios de sangre, a los voluntarios de la comunidad (AABB por sus siglas de de Hema-Qu\u00e9bec (H-Q) (Canad\u00e1), de la Cruz Roja Australiana (ARC), los Caribbean Regional Standards (CRS) y a pacientes que reciben la garant\u00eda de calidad Salud Referencias 1. Pan American Health Organization. Progress Report on the Regional Initiative for Blood Safety and Plan of Action for 2006-2010. 46th Directing Council. 57th Session of the Regional Committee, Document CD46/ 16. Washington, D.C. - U.S.A., 2005. 2. Pan American Health Organization. Transfusion Medicine in the Caribbean and Latin American Countries 2000-2003. Technical Documents. Access to Quality Products. Technology and Health Services Delivery Area. Essential Medicines, Vaccines and Health Technologies. Washington, D.C. - U.S.A., 2005. 3. Pan American Health Organization. National Blood Systems in the Caribbean and Latin Amer ican Countries: Basic Indic ators of their Status in 2004. Technical Documents. Access to Quality Products. Technology and Health Services Delivery Area. Essential Medicines, Vaccines and Health Technologies. Washingto n, D. C. - U.S.A., 2006. 4. Pan American Health Organization. Supply of Blood for Transfusion in the Caribbean and Latin American Countries in 2005. Baseline Data for the Regional Plan of Action for Transfusion Safety 2006-2010. Technical Documents. Access to Quality Products. Technology and Health Services Delivery Area. Essential Medicines, Vaccines and Health Technologies. Washi ngton, D.C. - U.S.A., 2007 . 5. Pan American Health Organization. Improving Blood Avai lability and Transfusion Safety in the Americas. 48th Directing Council. 60th Session of the Regional Committee, Document CD48/11. Washington, D.C. - U.S.A, 2008. 6. Carbajal M, Fernandez Cid G, Ganza M, Cruz Arano J, Cuellar Cuellar O, Rocha Castro R, Alvarez Aguilera RM, Sanchez Teran C. gre en los bancos de sangre de La Paz, Santa Cruz y Cochabamba. La Paz - B olivia, 2001. 8. Bork A, Zaninovic P, Lyng C, Ceron Meneses asociados a la donaci\u00f3n de sangre en la Va region. Hospital Carlos van Buren, Universidad Cat\u00f3lica de Valparaiso. Chile, 1999. 9. Ramirez H, Colombia, 2001. 10. Bustamante Castillo X, Fernandez Delgado X, Garcia Sol ano Z, Solis de sangre de Salud de Rica, Caja Costarricense Organizacion Mundial de la Salud, Costa Rica, 2002. 11. Alfonso Valdez ME, Lam Diaz Ballester Santovenia JM. voluntaria de sangre en Cuba. Cuba, 2002. 12. Villa de Pina M, Ruiz Camacho HJ, Erikson Santos A, Sosa S, Saenz del Ecuador. Secretar\u00eda Nacional de Sangre. Ecuador, 2000. 14. Fuentes de Sa nchez LP, Guevara de Bolanos A, Gutierrez Villacorta MD, sangre en Guatemala. Guatemala, 2000. 16. Adjudah S, Logan S, Nelson M, Gordon D. Anthropologica l study of voluntary blood donation in Kingston, Jamaica. Jamaica, 2001 . 17. Cruz Roja e sangre. Nicaragua, 2000. 18. de Castillo Z, Bayard V, Cedeno de Lopez A, de Cres po M, D, Panam\u00e1 durante el per\u00edodo del 2 de abril al 2 de mayo del a\u00f1o 2001. Panam\u00e1, 2002. 19. Chaparro de Ruiz Diaz C, mero Nacional de Salud. Asun ci\u00f3n - Paraguay, 2000. 20. Fuentes Rivera Salcedo J, Roca Valencia O. Perl antropol\u00f3gico del donante Salud. Lima - 2001. M, R, Aspectos socio-culturales con 2002. Ministerio de y Desarrollo Social, Di recci\u00f3n General de Salud Poblacional. Caracas - Venezuela, 2002. 22. Garcia Gutierrez M, Saenz de Tejada E, Cruz JR. Estudio de do Latchaman S, Khunja R, Budhoo D, Poon King C, Charles KS. Attitudes towards blood donation in Trinidad and Tobago. Transfusion Med 2007; 17:83-7. 24. Pan American Health Organization. Improving Blood A vailability and Transfusion Safety in the Americas. 48th Directing Co uncil. 60th Session of the Regional Committee, Resolution CD48.R7. 2008. 25. Daigneault S. Partnerships for success. Humanitarian partnerships. XI International Colloquium on Vol untary Blood Donation . Cairo - Egypt. 2008. 26. Ray D. Effective community partnership for blood donor re cruitment through voluntary action in West B engal, India. XI International Colloquium on Voluntary Blood Donation. Cairo - Egypt. 2008. 27. Alessandrini M. Community volunteerism and blood dona tion: altruism as a lifestyle choice. Trans Med Rev 2007; 21:307-16. 28. Lemmens KPH, Bos AER, Schaalma EP. Identifying blood donors willing to help with recruitment. Vox Sang 2008; 95: 211-7. 29. Schneider EC, Altpeter M, Whitelaw N. An innovative approach for building promot ion program capacity: a generic volunteer training curriculum. Gerentologist 2007; 47: 398-403. 30. Chrisman NJ. Extending cultural competence through systems change: academic, hospital, and community partnerships. J Transcult Nurs O, Diagne F, Carvalho GS. The future of health promotion in schools goes through the strengthening of teacher training at a global level. Promot Educ 2008; RJ Adverse reactions to prefaint reactions in whole-blood donors: an analysis of predonation measurements and their respective values. Transfusion 2008; 48: MD, Newman BH, Chambers LA, Hillyer CD, Benjamin RJ. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion 2008; 48: 1809-19. 35. France CR, Ditto B, France JL, Himawan LK. Psychometric Properties of the Blood Donation Reactions Inventory: a s ubjective measure of presyncopal reactions to blood donation. Transfusion 2008; 48: 1820-6. 36. General Assembly, International Society for Blood Transfusion. A code of ethics for blood donation and transfusio n. ISBT, 2000. Amended 2005. 37. Franklin IM. Is there a right to donate blood? Patient ri ghts; donor responsibilities. Transfusion Med 2007; 17:161-8. 38. Alaishuski LA, Grim RD, Domen RE. The informed consent process in whole blood donation. Arch Pathol Lab Med 2008; 132: 947-51.839. Goncalez TT, McFa rland W. Human immunodeciendy virus test-seeki ng motivation in blood donors. Sao Paulo - Brazil. Vox Sang 2006; 90: 170-6. 40. Goncalez TT, Sabino lles NA, Camone DA , McFarland W, Murphy EL. Know ledge, attitudes and motivations among blood donors in Sao Paulo, Brazil. AIDS Behav 2008; 12 (Suppl.4): S39-47. 41. http://www1.umn.edu/humanrts/instree/t4igha.html (UN HIV/ AIDS and Human Rights guidelines). 42. http://www1.umn.edu/humanrts/instree/b1udhr.htm (Universal Declaration of Human Rights). 43. http://www.who.int/gb/bd/PDF/BDe nglish/Constitution.pdf (Con stitution of the World Health Organization, Preamble). 44. http://www1.umn.edu/humanrts/instree/b3ccpr.htm (International Covenant on Civil and Political Rights). 45. http://www1.umn.edu/humanrts/instree/b2esc.htm (Int ernational Covenant on Economic Social and Cultural Rights). 46. http://www1.umn.edu/humanrts/instree/e1cedaw .htm (International Convention on the Elimination of All Forms of Discrimin ation Against Women). 47. http://www1.umn.edu/humanrts/oasinstr/zoas2dec.htm (Am erican Declaration on the Rights and Duties of Men). 48. http://www1.umn.edu/humanrts/oasinstr/zoas3con.h tm (American Convention on H uman Rights). 49. http://www1.umn.edu/humanrts/oasinstr/zoas10pe.htm ( Additional Protocol to the American Convention on Economic, Soci al and Cultural Rights. Protocol of San Salvador). 50. Contreras M. S ervicio Nacional de Sangre y Donaci\u00f3n Altrui sta. Encuentro EUROsocial. Santiago de Chile - Chile, 2008. 51. Echeverria O, Galeano A, Quinonez N, Paraguay, 2008. 52. Busch MP. Transfusion-transmitted viral infections: Building bridges to transfusion medicine to reduce risks an d understand epidemiology and pathogenesis. Transfusion 2006; 46: 1624-40. 53. Eder AF, Chambers LA. Arch Med 2007; Zak RJ, Lewandrowski KB. Does blood donor hist ory accurately reflect the use of prescription medications? A com parison of donor history and serum toxicologic analysis. Tr ansfusion 2006; 46:1402-7. 55. 3:11 J. Rethinking the donation experience: an integrated approach to im prove the efciency and the quality of each blood donation experience. Vox Sang 2004; 87 (Suppl 2): S72-5. 57. Pan American Health y Tecnolog\u00edas en Salud. Washington, D.C. - U.S.A., 2005. 58. Caribbean Epidemiology Center. Standards for Blood Banks a nd Transfusion Services. Caribb ean Regional Standar ds. Trinidad and Tobago, 2001. 59. American Association of Blood Banks. Standards for Blood Bank a nd Transfusion Service. 24th Edition. Bethesda, MD - U.S. A., 2006. 60. Council of Europe. Guide to the preparation, use and quality assurance of blood components. Reco mmendation No. R ( 95) 15. 13th edition 2007. 61. H\u00e9ma-Qu\u00e9bec. \"Donor qualication.\" Available from http://www.hema-quebec.qc.anglais.dondesang/qualidonneurs. htm . Consulted 10 May 2008. 62. Australian Red Cross Blood Service \"Giving blood.\" Available from: http://www.donateblood/ com.au. Consulted 10 M ay 2008. Standards. Trinidad and Tobago, 2 001. Recomendaciones para la n asegurar que el donan te es competente Asociaci\u00f3n de Sangre y la Cruz Roja Australiana (ARC) 16 Los Est\u00e1ndares de la establecieron Referencias Bibliogr\u00e1ficas Berger K. Informed Information or knowledge? Med L aw 2003; 22:743-750. Badami KG. Adverse reactions to blood donation s. JAMA 2008; 300: 1760. Borquez GE, Raineri GB, Bravo ML. The evaluation of decision m aking capacity i n health care and its relationship to informed consent. Rev Med Chi 2004; 132:1243-8. Eder AF, Hillyer r eactions to allogeneic whole blood donation by adolescents. JAMA 2008; 1760. Goldman M, Fournier E, Cameron-Choi, Seed T. Effect of changing the age criteria for blood donors. Vox Sang 2007; 92:368-72. Kluge EH. Competence, capacity, and informed consent: beyond the cognitive-competence m odel. Can J Aging 2005; 24:295-304. Kuchel GA, Avorn J, Reed MJ, Fields D. Cardiovascular respons es to phlebotomy and sitting in middle-aged and elder ly subjects. Med MK, Mayb erry Jf. Clin Med 2002; 2:523-6. Misje AH, Bosnes V, Heier HE. Recruiting and retaining young people as voluntary blood donors. Vox Sang 2008; 94:119-24. Mumford SE. Donati on without consent? Legal developments in bone marrow transplantation. Br J Haematol 1998; 101:599-602. Shehata N, Kusano R, Hannach B, Hume in a llogeneic donors. Transfus. Med 2004; 14:327-33. Symvoulakis CI. a de las poblaciones locales. Los donantes mayores edad \"at risk\" donors: A univariate analysis of effect of age and weight on the grade of donor reactions. Transf Apher Sci 2008; Epub prefaint reactions in whole-blood donors: an analysis of predonation measurements and their predictive value. Transfusion 2008; 48: 1799-808. Zou S, Musavi F, Notari EP IV, Fang CT, for the ARCNET Research Group. Changing age distribution of the blood donor population in the United States. Transfusion 2008; 48: 251-7. PESO CORPORAL (VER el cuerpo humano es proporcional al corporal (70 mL de cual representar establece y para H-Q el e s de 50 kg. Referencias Bibliogr\u00e1ficas Lentner C (ed). Blood Volume. Geigy Scientific Tables Volume 3. Medical Education Division, Ciba-Geigy Corporation, New Jersey. 8th Edition, 1984. Nadler SB, JU Hidalgo, T Bloch. Prediction of blood volume among human adults. Surgery 1962; 51: 224-32. Newman B. Blood donor suitability and allogeneic whole blood donation. Transfus Med Rev 2001; 15: BH. Vasovagal react ions in high school students: findings relative to race, risk factor synergism, female sex, and non-hi gh school participants. Transfusion 2002; 42: 1557-60. Newman BH. Vasovagal reaction rates and body findings in high- and low-risk populations. Transfusion 2003;43: 1084-8. Newman BH, Satz SL, M, Siefried BA. Donor reactions in high-school donors: the effects of sex, weight, and collection volume. Transfusion 2006; 46: 284-8. Tondon R, \"at risk\" donors: A univariate analysis of effect of age and weight on the grade of donor reactions. Transf Apher Sci 2008; Epub ahead of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion 1999; 39: 316-20. Wiltbank TB, Giordano Faint and prefaint reactions in whole-blood donors: an analysis of predonation measurements and their predictive value. Transfusion 2008; 48: 1799-808. Yuan S, Gornbein J, Smeltzer B, Ziman AF, Lu Q, Goldfinger D. Risk factors for acute, moderate to severe donor reacti ons associated with multicomponent A. Vasovagal reactions in blood do nors during and immediately af ter blood donation. Trans Med 2005; 15: 389-94. perturba las las colectas. El s menos de las reacciones adversas a la la de France CR, Rader A, Carlson B. Donors who react may not come back: analysis of repeat donati on as a function of phlebotomist ratings of vasovagal reactions. Transfus Aphe r Sci 2005; 99-106. France CR. Predonation water ingestion attenuated ne gative reactions to blood donation. Transfusion 2004; Lu CC, Diedrich A, Tung CS, Paranjape SY, Harris PA, Byrne D W, Jordan J, Robertson D. Water ingestion as pr ophylaxis against syn cope. Circulation 2003; 108: 2660-5. Newman B, E, Andreozzi C, Joychan S, P ocedic J, Heringhausen J. The effect of a 473-mL (16-oz) water drink on vasovag al donor reaction rates high-school stu dents. Tzolou A. V asovagal reactions in blood donors dur ing and immediately af ter blood donation. Trans Med 2005; 15:389-94. centr la coagulaci\u00f3n. El plasma, que es el componente l\u00edquido de la sangre, es rico en rojos. Los m\u00e1s importantes son los lo tanto, corresponden a los grupos sangu\u00edneos A, B, AB y respectivamente. Los individuos de grupo A, poseen anticuerpos anti-B en personas con B poseen anticuerpos anti-A en su plasma. Aqu\u00e9llos con AB no poseen ni anti-A ni anti-B. personas que no marcadores en los gl\u00f3bulos rojos y de los anticuerpos en plasma determina la compatibilidad mayor en la transfusi\u00f3n de sangre, ya que los anticuerpos que est\u00e1n presentes en el de unen eritrocitos extra\u00f1os induciendo su destrucci\u00f3n. sangre O. los gl\u00f3bulos rojos O pueden para a reciban y beban de al sitio de donaci\u00f3n sino que tambi\u00e9n promueve la interacci\u00f3n cordial entre el personal de los servicios de sangre y los donantes.Ninguno Fergusson D, Aziz A, Wilson K, Coyle D, H\u00e9bert P. The cost of allogeneic red blood cells -- a system atic review. Transfus Med 2003;13: 275-85. 2004; 87 (Suppl 2) Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Hirschler NV, Murphy EL, Busch MP. Quatifying losses to th e donated blood supply due to donor deferral and miscollection. Tranfusion 2004; 44:1417-26. Denesiuk L, Richardson T, Nahirniak S, Clarke G. Implementation of a redistribution system for near- outdate red blood cell units. Arch Pathol Lab Med 2006; Novis DA, Renner S, Friedberg R, Walsh MK, Saladino AJ. Quality indicators of blood utilization. Three Coll ege of American Pathologists Q-Probes Studies of 12 288 404 Red Cell Units in 1639 Hospitals. Arch Pathol Lab Med 2002; 126: 150-6. Participants of the Cost of Blood Consensus Conference, Charleston, S.C. - U.S.A. May 4-5 2003. The Cost of Blood: Multidiscplinar y Consensus Conference for a Standard Methodology. Transf Med Rev 2005; 19: 66-78. Pereira A. Blood inventory management in the type and screen era. Vox Sang 2005; 89:245-50 . Sime SL. n ser anticipar los la lejidad, la expansi\u00f3n de sus p\u00e9rdida como p\u00e9rdida y K, Frayne SM, Skinner KM, Sullivan LM. Health status among women with menstrual symptoms. J Women Health 2003; 12: 911-9. Boulton, F. Evidence-based criteria for the care and selection of blood donors, with some comments on th e relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transf Med cause anemia: endometrial thickness correlates positively with erythrocyt e count and hemoglobin concentration in premenopausal women. Am J Hum Biol 2006; 18:710- 3. Cote I, Jacobs P, Cumming D. Work Loss Associated With Increased Menstrual Loss in the United States . Obstet Gynecol 2002; 100: 683-7. Grover and hemoglobin iron def icits in menstruating women. Calculations based on var iations in iron requirements and bioavailability of dietary iron. Eur J Clin Nutr 2000; 54: 650-7. Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women's health. Epidemio l SJ. Impact of menst rual blood loss and diet iron deficiency among women in the UK. Br J Nutr 2005; 94: 557-64. Heath AL, Skeaff CM, Williams S, Gibson RS. The role of blood loss and diet in the aetiology of mild iron deficiency in premenopaus al adult New Zealand women. Public Clausen J, Byg Iron status in 268 Danish women aged 18-30 years: influence of menstruat ion, contraceptive method, and iron supplementation. Ann Hematol 1998; 77:13-9. Newman B. Iron depletion by whole-blood donation harms menstruating females: the current whole-blood-collection paradigm needs to be changed. Transfusion 2006; 46: 1667-81. Palep-Singh M, Prentice A. Epidemiology of Res Clin Obstet Gynecol 2007; 21:887-90. Punnonen Evaluation status of Finnish bloo d donors using serum transferrin recep tor. Transfus Med 1999; 9:131-4. Shankar M, C, Kadir RA. Review of quality of life: menorrhagia in women with or witho ut 2008 de donaci \u00f3n y cumplan el tervalo entre donaciones y el HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray G. Referral for mens trual problems: cross sectional survey of symptoms, reasons for referral, and management. Br Med J 2001; 323: 24-8. Warner PE, Critchley Murray GD. Menorrhagia II: Is the 8 0-mL blood los s criterion useful in management of complaint of menorrhagia? Am Martin NG. Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. Br J Hematol 2003; 120: 860- 6. de necesidades me tab\u00f3licas de la madre los de Biological mechanisms that might underlie iron's effects on fetal growth and pr eterm birth. T, Vanninen E, Heinonen S. Blood pressure and heart rate variabi lity analysis of orthostatic challenge in normal pregnancies. Clin Physiol Funct Imaging 2008; 7. Published ahead of print. James TR, Reid HL, Mullings AM. Are published standards for haematological indices in pregnancy appl icable across populations: an evaluation in healthy pregnant Jamaican BMC Pregnancy and Chil dbirth 2008; 8:8. Kaaja RJ, Greer Manifestations of pregnancy. JAMA 2005; 294:2751-7. Lain KY, Catalano A, Forsum E. Changes in basal metabolic rate during pregnancy in relation to changes in body weight and composition, ca rdiac output, insulin-like growth factor I, and thyroid hormones and in relation to fetal growth. Am J Clin Hvas A-M. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women. Eur J Haematol 2007; 79: 39-46. M\u00fcngen Perinat Med 2003; 31:420-6. Pike IL. Maternal stress and fetal responses: evolutionar y perspectives on pr eterm delivery. Am J Hum Biol 2005; 17:55-65. Salas SP, Marshall G, Gutierrez BL, Rosso P. Time course of maternal plasma volume and hormonal changes in wom en with preeclapsia or fetal growth restriction. Hypertension 2006; 47: 203-8. Sprumont D, Roduit G, Hertig Pea A. The contribution of jur isprudential comparative law to the drawing up of an international custom in life sciences: the example of the status of the embryo. J Int Bioethique 2006; 17:71-94. Volman MN, Geijn HP, Heethaar RM, de Vries JI. Haemodynamic changes in the second half of pregnancy: a longitudinal study with y alergias, provee los nutrientes y ni\u00f1o por lactancia materna asociado re la leche tienen menor riesgo de cance r de ovario y de a. Los nutrientes presentes en la materna transferidos al beb\u00e9 a tr av\u00e9s de la leche y da\u00f1arlo. El VIH y la tuberculosis tambi\u00e9n pueden ser K. Does maternal iron supplementation during the lactation period affect iron status of exclusively into maternal and child heal th programmes: scalling up of exclusive breastfeeding. Maternal Briton C, McCormick FM, MJ, Wade A, King SE. Suppor t for breastfeeding mothers (Review). The Cochrane Librar y 2008; 4. Clifford J, McIntyre E. Drevon CA. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med 2006; 19:397-406. Health 2007; 52: 564-70. Lowdon J. start! Pregnancy , lactation and Davey Smith G, Cook DG, Bergstrom E, Black S, Wadsworth ME, Fall CH, Nie J, Huxley DR, SM. Does initial breastfeeding lead to lower blood cholester ol in adult life? A quantitative review of the evidence. Am J Clin Nutr 2008; 88: 305-14. Theobald H ealth Care 2007; 17: 45-9. World Health Organization. Global Strategy for Infant and Young Child Feeding. Geneva, Switzerland, 2003. Recomendaciones para la Educaci\u00f3n y u obturaci\u00f3n Sin embargo, en el caso de la extracci\u00f3n, cirug\u00eda dental o tratamiento K, Abe S, Okuda K. Professional oral health care by dental hygienists reduced respiratory infecti ons in elderly persons requiring nursing care. Int J Dent Hyg 2007; 5: 69-74. Burden DJ, Coulter WA, Johnston CD, Mullally B, Stevenson M. The prevalence of bacteraemia on removal of fixed orthodontic appliances. Eur J Orthod 2004; 26:443-7. Ito HO. Infective endocarditis and dental Fever of unknown origin due to dental infections: cases report and review. Am J Med Sci 2007; 333: 109-10. Lucas VS, Kyriazidou A, Gelbier M, Roberts GJ. Bacteraemia following debanding and chain adjustment. Eur J 2007; 29:161- 5. Poveda Roda R, C, Munoz MM, Sa rrion Perez G. Bacteraem ia originating in the oral cavity: A Review. Med Oral Pathol Oral CIr een periodontal disease, bacter ial vaginosis, J Tom\u00e1s M, Potel Medina J, Diz P. Prevalence , duration and aetiology of bacteraemia following dental extr actions. Oral Dis 2007; 13:56-62. Waldman BJ, Mont MA, Hungerford DS. Total knee arthroplast y infections associated with odontol\u00f3gicos que Bibliogr\u00e1ficas Centers for Disease Control and Prevention. Recommended Adult Immunization Schedule -United States. October 2007-September 2008. MMWR 2007; 56: Q1-4. Centers for Disease Control and Prevention. Recommende d Immunization Schedules for Persons Aged 0-18 Years. http://www.cdc.gov.vaccines/recs/acip. C onsulted 19 November 2008. Gerlich WH. Breakthrough of hepatitis B virus escape mut ants after vaccination and virus r eactivation. J Clin Virol MC, Nates SV. measles in the D, Guerr a M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, Sun B, Hull HF. Human rabies prevention -United States, 2008. Recommendations of the Advisory Com mittee on Immunization Practices. MMWR 2008; 57: Seward JF. Advisory Co mmittee on Immunization Practices, Cent ers for Disease Control and Prevention (CDC). Prevention of Varicella: recommendations of the Advisory Committee on future. Nat Med 2005 ; 11(4 Suppl) :S5-11. World Health Organization. Rabies Vaccine WHO position Weekly Epidemiol Rec cl\u00ednica por las caracter\u00edsticas de los dichos. La mayor parte de medic inas que toman los donantes no requieren medicaciones son AABB: Se acepta al donante 36 lue la ingesti\u00f3n de aspirina. CRS: aspirina, me Referencias Bibliogr\u00e1ficas American Society of Health-System Pharmacists. AH FS Consumer Medication Information. http://www.ncbi.nlm.nih.gov/books/bv.fcgi ?rid=medmaster.TOC&depth=1. Consulted 25 Septem ber 2008. Andres E, Fedeciri L, Weitten T, Vogel T, Alt M. Recogniti on and management of drug-induced acute neutropenia and agranulocytosis. Expert Opin Drug Saf 2008; 7:481-9. Boethius G. Recording of drug prescriptions in the count y of J\u00e4mtland, Sweden. III. Drugs presented for blood dono rs in a 5 year period. Eur J Clin Pharmacol 1977; 12:45-9. Ferner RE, Dunstan JA, Chaplin S, GM. Drugs in donat ed blood. Lancet. 1989; McEv oy P, Busch MP, Tomasulo PA. Safety and donor acceptance of an abbreviated donor history questionnaire. Transfusion 2006 ; 46:1745-53. Melanson SE, Stowell CP, Flood JG, Lewandrowski EL, Zak RJ, Lewandrowski KB. Does blood donor history accurately r eflect the use of prescription medications? A comparison of donor history and serum toxicologic analysis. Transfusion 2006; 46:1402-7. Pisciotto P, Sataro P, Blumberg N. Incidence of adverse reactions in blood donors taking antihypertensive medications. Transfusion 1982; 22:530-1. Schulz M, Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 2003; 58:447-74. Stichtenoth DO, Deicher HR, deferral necessary? Eur J s e sienten bien la end\u00e9micas de las de alta prevalencia de HIV, y las \u00e1reas en las que est\u00e1 presente la variante de Unido, e ntre el 1ro. de enero de 1980 y el 31 de enero de 1980 y el 31 de diciembre de 1996, as\u00ed como a los desde el tie mpo pasado el y en Francia forma permanente. Referencias Bibliogr\u00e1ficas SH, Fielding R, Morisky DE. Sexually transm itted infections in traveler s: implications f or prevention and control. Clin Infect Dis 39: 533-8. Freedman DO, We JS, Pandey P, Cetron MS. GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J M ed 2006; 354:119-30. Hiltunen-Back Epidemics due Dis 2002; 29:746-51. Schmunis GA, Corber SJ. Tourism and Emerging and Re-emerging Infectious Diseases in the Americas: What Physicians Must Remember for Patient Diagnosis and Care. Braz J Infect Dis 1999; 3:31-49. World Health Organization. International Travel and H ealth 2008. Situation as on 1 January 2008. Geneva, Switzerland. Recomendaciones para la Educaci\u00f3n y en relaci\u00f3n los individuos que de a los l y la aparici\u00f3n la de mediadores almacenamiento, por lo tanto, pueden ser transfundidos al receptor incluyen las criterios de selecci\u00f3n de los donantes. Referencias Bibliogr\u00e1ficas American Academy of Family Physicians. Food allergies: what you should know. Am Fam Physician 2008; 77: 1687-8. Biagini RE, MacKenzie BA, Sammons DL, Smith JP, Strile y CA, Robertson SK, Snawder JE. Evaluation of the prevalence of antiwheat-, anti-flour dust, and anti-alpha-amylase specific IgE antibodies in US blood donor s. Ann Allergy Asthma Immunol 2004; 92: 649-5. Deadock SJ. Exp Immunol 2008; 153: 151-61. Dobson transpla ntation. GA. Allergic reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med 2003; 127: 316-20. Kuroswsky K, Boxer 2008; 77: 1687-86. MedlinePlus. Allergy. http://www.nlm.nih.gov/medlineplus/allergy.html Consulted 18 November 2008. Stern A, van Hage-Hams ten M, Sondell K, Johansson SG. Is allergy screening of blood donors necessary? A comparison between questionnaire answers and the presence of circulating IgE antibodies. Vox Sang 1995; 69:114-9. Stewart MG. Identification and management of undiagnosed and undertreated allergic rhinitis Elhefni H. Testing for allergic disease: parameters considered an d test value. BMC Fa m Pract 2008; 9:47. Wrobel JP, O'Hehir RE, Douglas JA. adult s. Aust Fam Physician 2008; brazo de asepsia de la piel del donante y el ambien te que se la al influir sangre la la evaluaci\u00f3n del lugar de examine el para asegurarse de que intra venosas. Ef fects of skin method, deviation bag, and bacterial screening on cl inical safety of platelet transfusions in the Netherlands. Transfusion 2006; 46 : 476-85. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Program 2003; pp Roy A, Mahajan P, Smith R, Charlett A, Barbara JA J. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004; 86: 178-82. McDonald CP, Lowe P, Roy A, Robbins S, Hartley S, Harrison JF , Slopecki A, Verlander N, Barbara JA. Ev aluation of donor arm disinfection techniques. Vox Sang 2001;80 :135-41. McDonald CP. Bacterial risk reduction by improved donor arm disinfection, diversion and bacter ial screening. Transfus Med 2006;16: 381-96. Vasconcelos E, Seghatchian J. Bacterial contamination in blood components and preventative strategies: an overview. Transfus Apher Sci 2004 ;31 :155-63. Wagner SJ. Transfusion-transmitted 157- hasta que las lesiones se curen. que los establecimientos que realizan \" piercing \" y h diferir se realizado perforaciones cosm\u00e9ticas. AABB, ARC, CoE se realizaron perforaciones hizo con agujas Kruk-Jeromin J. Ar e body piercing and tatooing safe f ashions? Eur J De rmatol 2006; 16: 572-5. Armstrong ML, Koch JR, Saunders JC, Roberts AE, Owen DC. The whole picture: risks, decision making, purpose, regulations, and the future of body piercing . Clin Dermatol endocarditis after body art: a review of the literature and concerns. J Adolesc Health 2008; 43: 217-25. Baldo body pierci ng indicators of risk-taking behaviour hea lth value. J Health Psychol 2005; 10:831-41. Hwang LY, Kramer JR , Troisi C, Bull L, Grimes Z, Lyerla R, Alter MJ . Relationship of cosmetic pr ocedures and dr ug use to hepatitis C and hepatitis B virus infections a piercings i n the United States: a national data set. J Am Acad Dermatol 2006; 55:413-21. Levin L, Zadik Y. Oral piercing : complications and side effects. Am J Dent 2007; 20:340-4. Mapagu MC, Martin Screening for he patitis C in sexual clinic attendees. Sex Health body art (body piercing and tattooing) in university undergraduates and incidence of medical complications. Mayo Clin Proc 2002; 77:29-34. Meltzer DI. Complications Teles SA. Tattooing and body piercing as lifestyle indicator of risk behaviors i n Brazilian adolescents. Eur J Epidemiol 2006; 21: 559-60. Panconesi Chil 2006; 134:1322-9. Polizzotto MN, Wood EM, Ingham H, Keller AJ. Australian Red Cr oss Blood Service Donor and Product safety Team . Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australia n experience 2000 through 2006. Transfusion 2008; 48: 55-63. Schorzman CM, Gold MA, Downs JS, Murray PJ. Body ar t: attitudes and practices regarding body piercing among urban undergraduates. J Am Osteopath Assoc sido asociados con sangrado, infecciones locales, riesgo de de en del endocarditis after body art: a review of the literature and concerns. J Adolesc Health 2008; 43: 217-25. Baldo V, Des 2008; 14: 1646-54. Correa M, Gisselquist D. Reconnaissance assessment of r isks for HIV transmission through health care and cosmetic services in India. Int J STD AIDS 2006; 17: 743-8. De Nishioka and transfusion-transmitted diseas es in De MacLean JD. Tattooing and risk for transfusion-transmitted diseases: the role of the type, number and design of the tattoos, and the conditions in which they were performed. Epidemiol Infect 2002; 128:63-71. Garland tattooing as a potenti ally important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltimore) 2001; 80: 134-51. Hand WL, Vasquez Y. Risk factors for Hepatitis C on the Texas-Mexico border. Am J J Psycol 2005; 10: 831-41. Hwang LY, Kramer JR, Troisi C, Bull L, Grimes CZ, Lyerla R, Alter MJ. Relationship of cosmetic pr ocedures and drug use to hepatitis C and hepatitis B virus infections in a low-ri sk population. Hepatology 2006; 44:341-51. Kaatz . Screening f or hepatitis C in sexual health clinics attendees. Sex Health 2008; 5: 73-6. Polizzotto MN, Wood EM, Ingham H, Keller AL, Australian Red Cross Blood Donor Service and Pr oduct Safety Team. Reducing the r isk of transfusion-transmissible viral infections through blood donor selection: the Australian experience 2000 through 2006. Transfusion 2008; 48: 55-63.32 Recomendaci\u00f3n de la OPS: Los de coca\u00edna factores de riesgo m\u00e1s signicativos para la infecci\u00f3n con los de hepatitis y el VIH, lo cual es consecuencia del uso com\u00fan transfusi\u00f3n de contaminada. AABB, CoE, RE, CF, Chitwood DD. Sex related H IV risk behaviors: differential risks among i njection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend 2000; 58: 219-26. Campo N, A, A. G virus i nfection in intravenous drug u sers with or without D, AM. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang 2000; 79 (3):138-44. La Torre G, Miele L, Gasbarini G, Ficarra MG, Matera A, dri G, Grieco A, and HCV- Southeern Lazio Collaborative Group. Correlates of HCV seropositivy among positive ler FD, Effier PV. A case control investigation of hepatitis C risk factors in Hawaii. Hawaii Med J 2005; 64:296-304. Li JR, Gong RY, Tian KL, Wang J, Wang YX, Huang JH. Study on the blood-borne vir us co-infection and T. lymphocyte subset among intravenous users. 13 (16):2357-62. Macias J, Palacios RB, Mira JA, Mer chante N, Corzo JE, Pineda JA. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack. Liver Intern 2008; 28: 781-6. MedlinePlus. Drug Abuse. MedlinePlus. Cocaine. http://www.nlm.nih.gov/medlineplus/cocai ne/htlm. Consulted 18 November 2008. MedlinePlus. Drug Heroine. http://www.nlm.nih.gov/medlinepl us/heroine/htlm. Consulted 18 November 2008. Mussi ADH, de Almeida Pererira RAR, Correa e Silva VA, Bringel Martins RM, Duran Souto FJ. Epidemiological aspects of hepatitis C virus infection among HIV-infected individuals in Mato Grosso State, Central Brazil. Hepatitis-C prevalence in an urban native-American clinic: a prospect ive screening study. J Natl 99:389-92. Grosskurth H , Gupte MD. Risk factors for HIV infection in injection drug users and evidence of onward transmission of HIV to their sexual partners in Chennai, India. J Acqu ir Prevalence of chronic hepatitis C virus genotypes among patients between 21 and 65 years old in Puerto Rico. PR H ealth Sci J HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Flehmig B. Evidence of multiple hepatitis virus infecti ons in autopsi ed materials of intravenous drug addicts. Ig Sanita Pubbl 2005; 61 (5):435-50. Shirin Islam M, Islam MN. Preva lence and risk factors of hepatitis B virus, hepat itis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. J Health Po pul Nutr 2000; 18: que las u tiliz\u00f3. Los B y hepatitis C, para que protejan su salud y la de sus de drogas adictivas, SEXUALES El humana adquirida, y las h epatitis virales m\u00e1s un grupo espec\u00edco de personas. En \u00e9l incluye no s\u00f3lo varones y bisexuales que se reconocen tales, a tambi\u00e9n 1977, de ben ser diferidos en forma permanente. L as personas en pa\u00eds de Central diferidos forma permanente. Las personas que hayan en lo establecido arriba son diferidas por o establece que las parejas sexuales de L parejas sexuales de con os hombres son forma Las personas que contacto con alguien que es positivo tiene hepatitis, vez exo H. permanente. sexo desde 1977 diferidas Referencias Bibliogr\u00e1ficas Atkins M, Nolan M. Sexual transmission of Curr Opin I nfect Dis 2005; 18:67-72. Belza MJ. Risk of HIV infection among male sex workers in Spa in. Sex Transm Infect 2005; 81:85-8. Creese A, Floyd K, Alban A, L. of HIV/AID S interventions in A frica: a systema tic review of the evidence. Lancet 2002; 359:1635-4 3. Gambotti L, Batisse D, Colin-de-Verdiere N, Delaroque-Astagnea u E, Desencios JC, Dominguez S, Dupont C, Duval X, Gervais A, Ghosn J, Larsen C, Pol S, Serpaggi J, Simon A, Valantin MA, Velter A, Acute hepatitis C collaborating group. Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Euro Surveill 2005; 10:1 15-7. Goncalez McFa rland W. Human immunodef iciency virus test-seeking motivation in blood donors, Sao Paulo - Brazil. Vox Sang 2006; 90:170-6. Hoyos-Orrego A, Massaro-Ceballos M, Ospina-Ospi na N, Tobon-Pereira J, Jar amillo-Hurtado J, Rugeles-Lopez MT. Serological markers and risk factors for hepatitis B and C viruses in patients infected with human immunodeficiency virus. Rev Inst Med Trop Sao Paulo 2006; 48: 321-6. Johnson WD, Diaz RM, Flanders WD, Hill AN, Holtgrave D, Malow R, McClellan WM. Behavioral in terventions to r educe risk of sexual transmission of HIV amon g men who have sex with men (Review). Cochrane Database Syst Rev 2008; 16. King SM, AuBuchon P, Squires B, Shaul RZ. Co nsensus statement from the consensus conference on blood-borne human inmunodeficiency virus and hepatitis: optimizing t he donor-selection Vox Sang 2002; 83:188-93. Leiss W, Tyshenko M, Krewski D. Men having sex with men donor deferral risk assessment: an analysis using risk mana gement principles. Transf Med Rev 2008; 22: 35- 57. Morbidity and Mortality Weekly Report. Epidemiology of Aid s, United States 1981-2005. MMWR 2006, 55:589. Musto, JA, Seed CR, Law M, Keller AJ, Kaldor JM. Estimating the risk of blood donation associated with HIV risk behaviou rs. Transf Med 2008; 18: 49-54. Pando High human immunodeficiency virus type 1 seroprevalence in men who have sex w ith men in Buenos Aires, Argentina: risk factor for infection. Int J Epidemiol 2003; 32:735-41. Sanchez J, Lama JR, Kusunoki L, Manrique Goicochea P, Lucchetti A, Rouillon M, Suarez I, Montano S, Sanchez JL, Tabet S, Hughes JP, Celum C. HIV-1, sexually transmitted infections, and sexual behavior trends among men who have sex with men in Lima, Peru. J Acquir Immune H, VIard JP, Piketty C, Rouveix E, Rouzioux C, Weiss L, Pol S. Sexually transmitted acute infection with clustered genotype 4 hepatitis C virus in HIV-1-infected men and inef ficacy of early antiviral therapy. AIDS 2006; 20:233-40. Tabet S. Sanchez J, Lama J, Goicochea P, Campos P, Rouillon M, Ca iro JL, Watts D, Celum C, Holmes KK. HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. AIDS 2002; 16:1271-7. UNAIDS. 2006 Report on the global AIDS pandemic. A UNAIDS 10th Anniversary special edition. At risk and negl ected: four key populations, pp103- 122. Geneva, 2006. UNAIDS. 2008 Report on the global AIDS epidemic. Geneva, 2006. UNAIDS. UNAIDS Annual Report. Kn owing your epidemic. Geneva, 2007. UNAIDS/World Health Organization AIDS epidemic update, Dece mber 2005. UNAIDS/World Health Organization AIDS epidemic riesgo por de la tem peratura corporal - es una de las respuestas del cuerpo a lesiones y Galli SJ, inf lammation. Nature 2008; 454: 445-54. Henker R, AACN Neuroscientist 2008; 14: JP, Steiner AA, Turek VF. Fever and hypother mia in systemic inflammation: recent discoveries and revisions. Hosokaw a Phayre AN, Robbins JR, Roberts JL, Kobayashi S, Matsumura K, Saw chencko PE, Romanovsky AA. Cellular and molecular bases of the initiation of fever. PLoS Biol 2006; 4: e284. Zhang HG, Metha K, Guha C. Hyperthermia (mm sist\u00f3lica y mm en la resistencia de las peque\u00f1as arter ias, con otros da\u00f1os Los que las personas que toman medicamentos mantiene puede ser aceptada. AABB, CoE, CRS y H-Q asisten a donar m\u00e1s de 180 mm Hg de presi\u00f3n sist\u00f3lica y no m\u00e1s de 100 mm de H g de presi\u00f3n diast\u00f3lica en el mom ento de la donaci\u00f3n. Referencias Bibliogr\u00e1ficas American Heart Association. Blood pressure. http://www.americanheart,org/presenter.jhtml?identifier=4473. Consulted on 13 N ovember 2008. B yrne N, Ditto B. Alexithymia, cardiovascular reactivity, an d symptom reporting during blood donation. Psychosom M ed 2005; 67:471-5. Casiglia E, Biasin R, Cavatton G, Capuani M, Marotti A. On Lower blood pressure values in blood donors. Jpn Hea rt J 1996; 37:897-903. Diamond JA, Phillips RA. Hypertensive heart disease. Hyper tens Res 2005; 28:19 1-202. Fu Q, Witkowski S, Okazaki K, Levine BD. Effects of gender and hypovolemi a on sympathetic neural r esponses to Roychowdhury P. Seasonal variation of bl ood pressure in young normotensive. Nepal Med Coll J 2003; 5:100-1. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressur e monitoring and r isk of cardiovascular disease: a population based study. Am J Hyper tens 2006; 19:243-50. Pisciotto P, Sataro P, Blumberg N. Incidence of adverse reactions in blood donors taking antihypertensive medications. Transf usion 1982; 22:530-1. Pramanik T, Adhikary P, Roychowdhury P, Ghosh A. Alteration of blood pressure among the donors i n a blood donation camp. Mymensingh Med J. 2005; 14:189-90. Rosei EA, Muiesan J, Eckstei n R. A pilot study of continuous am bulatory monitoring of blood pressure in repeated preoperative autologous blood donation. Transfusion debe 180 mm Hg y la diast\u00f3lica no debe exceder los m\u00ednima ac por CoE y CRS es de 50 pulsaciones por minuto. CoE y CRS establecen Ann Med. 341-9. Ibler M, S Lage. Influence of blood-t aking procedure on heart f blood donors. Anaesthesiol Scand 1984; M Lee. Assessment of training-induced autonomic adaptati ons in athletes with spectral analysis of va riability signals. Jpn J Physiol. 1995; 45:1053-69. Witting MD, RL Wears, S Li. Defining the positive tilt test: a study of healthy adults with moderate acute blood loss. Ann Emerg Med. 1994; donantes con fluct\u00faan g/L y 151 g/L de sangre en mujeres y entre 138 g/L y 172 g/L en hombres. hematocrito se la por de los sobre residencia donante, deben ser considerados 125 status and risk-profiling for deficiency in New Zeland blood donors. NZ Med J 2008; 121: 50-60. Badami KG. Adverse JAMA 2008; 300: 1760. Boulton F. Evidence-based criteria for the care and selection of blood donors, with so me comments on the relationship to blood supply, and emphasis on the management of blood-donation iron depletion. Transf Med 2008; 18: 13-27. Boulton F. 87(Suppl2): 522-4. Can\u00e7ado RD, Alonso FF, Langhi Junior DM, de C Alves R. Iron deficiency in blood donors. Sa o Paulo Med J 2001; 119: 132-4. Di Santolo F, Cauci S. Anemi a and iron status in young fertil e non-professional donation among adolescents. JAMA 2008; 1760. Farrugia A. Iron and blood donat MJ, Cascales A, Martienz C, Corral J, Vicente V, Rivera J. Evaluation of four rapid methods for hemoglobin screening of whole blood donors in mobile collection settings. Transfus Apher Sci 2007:36:235-42. Magnussen K, Bork N, Asmussen L. The effect of stan dardized protocol for iron supplement ation to blood donors low in h emoglobin concentration. Transfusion 2008; 4: 749-54. Newman B. Iron depletion by whole-blood donation harms menstruating females: The current whole-blood-collection paradigm needs to be changed. Transfusion 2006; 46: 1667-81. Skikne B, Lynch S, Borek D, blood donati on. Clin Haematol 1984; 13: 271-87. World Health Organization, 2001. Iron deficiency anemi a. Assessment, prevention and contr ol. A guide for programme managers. Geneva. Yuan S, Gornbein J, Smeltzer B, Ziman AF, Lu Q, Goldfinger D. Risk factors for acute, moderate to severe donor reacti ons associated with multicomponent apheresis collections. Transfusion utilizado el sangu\u00edneo promedio aceptado es de 70 mL de sangre de peso corporal. Una unidad est\u00e1ndar donante. desmayos os adversos la son comunes los Est\u00e1ndares Regionales no sean cada donante m\u00e1s que 10,5 mL de CoE considera que una extracci\u00f3n mL es que no se del debe exceder 10,5 las y de ingesta de hierro.Referencias Bibliogr\u00e1ficas Lentner C (ed). Blood volume. Geigy Scientific Tables Volume 3. M edical Education D ivision, Ciba-Gei gy Corporation, New Jersey. 8th Edition 1984. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume among hum an adults. Surgery 1962; 51: 224-32. Newman BH, Satz SL, Donor reactions in high-school donor s: the effects of sex, weight, and collection volume. Transfusion 2006; 46:284-8. Triedman JK, Cohen tress alters autonomic TB, Giordano GE, Kamel H, and prefaint reactions in whole-bl ood donors: an analysi s of predonation measurements and their predictive value. Transfusion 2008; 48: 1799-808. Yuan S, Lu Q, Goldf inger D. Risk factors for acute, mode rate to severe donor reacti ons associated with multicomponent apheresis de la circulante l A una persona bien ocho semanas. Para colecta de el m\u00ednimo es 48 de 472 en local de donantes.Referencias Bibliogr\u00e1ficas Boulton F. Evidence-based criteria for the care and selection of blood donors, with some comments on the relations hip to blood suppl y, and emphasis on the management of donation-induced iron depletion. Transfus Med 2008; 18:13-27. Djalali M, effect of repe ated blood donati ons on the iron status of I ranian blood donors att ending the Iranian blood transfusion organ ization. Int J Vitam Mohan H, Ravi Kumar A. Evaluation of iron stores in blood donors by serum ferritin. Indian J Med Res 2006; 124:641-6. Newman B. Iron depletion by whole-blood donation harm s menstruating femal es: the current whole-blood-collection paradigm needs to 2006; 46:1667-81. Norashikin Roshan TM, Rosline H, Rapiaah M. A study of serum ferritin levels among mal e blood donor s in Hospital Universiti Sains Malaysia. Sou theast Asian J Trop Med Pub Heal th 2006; YO. en hombres si se asocia a elevaci\u00f3n hierro; \u00f3 2) presencia de mutaci\u00f3n produci\u00e9ndose disminuci\u00f3n la J T. Genetic mechanisms un derlying regulation of hemoglobin m ass. Adv. Exp Med Finazzi G, Barbui T. Evidence and expertise in the manage ment of polycythemia vera and Z, Schroyens W , Schwarz J. WHO bone marrow features and Eu ropean clinical, molecular, and pathological (ECMP) criteria for the 2007; 31: 1031-8. ealth Organiza tion Diagnostic Criteria for polycythemia ver a, essential thrombocytosis, and primary myelofibrosis: an alternative proposal. Blood Tefferi management and the prospec therapy . Am J Hematol and after Dameshek. Leukemia 2008 ; Recomendaci\u00f3n de la c\u00e9lulas la activaci\u00f3n de virus los riesgos potenciales Hodgkin. Aunque ha de con los que no tratamiento denido de tiempo despu\u00e9s de haber completado el tratamiento es consider ado curado por diez a\u00f1os. ARC considera que en la mayor\u00eda de los sos las posible que el c\u00e1ncer ha remitido y no va a recidivar. Sin embargo, personas una Storm HH. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecogn ized malignancies and other in organ donors. Transplantation 2002; 74:1409-13. Blomberg J, M\u00f6ller T, Olsson H, Anderson H, Jonsson M. Cancer morbidity in blood recipients--resu lts of a cohort study. Eur J Cancer 1993; 29:2101-5. Buell JF, Beebe Hanaway G, Wideroff L, Nyr\u00e9n O, Melbye M. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet 2007; 369:1724-30. Mayo Clinic. Cancer prevention. http://www.mayoclinic.com/ print/cancer-prevention/ Consulted 18 November 2008. MedlinePlus. Cancer. http://www.nhl.nih.gov/medlineplus/ cancer.html 18 November 2008 P, Tyndall A, Urbano-Ispizua A, Lazarus HM, Gratwohl A. Transmission of donor illness by stem cell transplantation: should screen ing be different in older donors? Bone Marrow Transplant 2004; 34:657-65. Purdy E, Jensen K, Perry E, Gorlin J. Success of rei nstating donors previously deferred five years for history of ca ncer. Abstract. Transfusion 2005; 45: Caprio M, and Costa AN. A population-based study of cancer incidence in solid organ transplants from donors at various risk of neoplasia. Transplantation 2007; 83:13-6. Vargas SO, Cannon ME, Benjamin RJ, Longtine JA. Transfusion with blood from a donor wi th chronic myelogenous leukemia: persistence of the bcr/abl the recipient. Transfusion 1999; 39:387-91. Vamvakas EC. Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphoma. Transfus Med Rev 2000;14: 258-68. DIABETES Diabetes de insulina. La diabetes del inyectable. La diabetes del tipo es un i ncremento en los requerimientos de insulina con la la m La cardiomiopat\u00eda de diabetes del tipo 1, si se indica y cumple una dieta adecuada H-Q; ARC requiere consultar individuos se infecciones como la hepatitis B y C, y el virus del papiloma, pueden redundar en la disminuci\u00f3n Pu lmonary complications in diabetes m ellitus: the r ole of glycemic control. Curr Drug Targets Inflamm Allergy 2004; 3:455-8. Centers for Disease Control and Prevention. National diabetes fact sheet. http://www.cdc.gov/diabetespubs/general.htm . C onsulted 13 November 2008. Nair M. Diabetes mellitus, part 1: physiology and complications. Br J Nurs 2007; Picardi S, Afeltra D. Diabetes in chroni c liver disease: from old concepts to new evidence. Diabetes Metab Res Rev 2006; 22:274-83. Sadzeviciene R, Paipalie ne G, Zilinskas The influence of microvascular complicati ons caused by diabe tes mellitus on the inflammatory pathology of 2005; 7:121-4. EPILEPSIA/CONVULSIONES de los Estados Unidos (US National Institute of Neurogical Disorders and Stroke por su nombre en ingl\u00e9s) como \"un desorden cerebral de falta de sue\u00f1o, a los excesos con el alcohol y al uso de coca\u00edna. Por lo tanto, mantener un con diagn\u00f3stico d e diabetes pueden sangre si su enfermedad (ausencia de sed poliuria). glucosa en la Bibliogr\u00e1ficas Epilepsy Foundation. Living w ith Epilepsy. Recogni zing Seizure Triggers http://www.epilepsyfoundation.org/about/quickstart/newlydiagnosed/qsliving/ Consulted 18 November 2008. Gilliam FG, Mendiratta A, Pack AM, Bazil CW. Epileps y and common comobidities: improving t he Fuchs N, Salama A. Epilepsy is not a contraindication f or autologou s blood donation. Transd J, Twellaar M, van Merode T, Knottnerus A. Incidence of epilepsy and predi ctive factors of epileptic and non-epileptic seizures. Seizure 2005; 14: 175-82. Krumholz A, Ness PM, Hauser WA, Douglas DK, Gibble JW. Regulations prohibiting blood donation by individuals with seizur es or epilepsy are not necessary. Med Law 1997;16: 339-47. Lawn ND, Bamlet WR, Radhakrishnan K, O'Brien PC, So EL. Injuries due to seizures in persons with epilepsy: a population-base d study. Neurology 2004; 63:1565-70. CW, syncope in blood donors. Ann Neurol 198 2; 11:525-8. Mayo Clinic. Epilepsy. http://www.mayoclinic.com/print/epilepsy/DS003 42/method= print Consulted 18 November 2008. National Institute of Neurological Disorders and Stroke. N INDS Epilepsy Information Page . http://www.ninds.nih.gov/disorders/epileps y/epilepsy.htm?css=print Consulted 18 November 2008. Strauss RG. Rationale for medical director acceptance or rejection of allogeneic plateletpher esis donors with underlying medical disorders. Van eukelom LH, Mei nhardi H. Blood donation, a risk for epileptic patients? Vox Sang 1986; 51:148-51. ENFERMEDAD DEL as a cause of acute myo 2002; 21; 2: 15. Carrier M, Gal G, Well PS, Fergusson D, Ramsay T, Rodger MA. Systematic review: the Trousseasu syndrom e revisited: should w e screen extensively for cancer in patients with venous thromboembol ism? Ann Intern Med 2008; 149: 323-33. Kahn R, Robertson RM, Smith R, Eddy D. The impact of prevention on reducing the burden of cardiovascular diseas e. Diabetes Care 2008; 31:1686-96. Kasper P, Lynch R, Buzello W. All adverse events in autologo us blood donors with cardiac disease are not necessarily caused by blood don ation. Transfusion 198l; 38:669-73. Patel A, Markowitz -a condition to prevent. Dermatol Online J 2008; 14:13. Strauss R. Medical Director Acceptance or Rejecti on of Allogenic Plateletpheresis Donor s with 17:111-7. Las personas historia de enfermedad cardiovascular, sin s\u00edntomas enfermo per\u00edodo de incubaci\u00f3n - el tiempo que transcurre entre la exposici\u00f3n a los organismos patog\u00e9nicos y la en el caso del SIDA, la hepatitis, enfermedad de Chagas y la enfermedad m\u00e9todos Dodd RY . Emerging infectious disea ses that DJ, Chamone DF , Busch MF. Prevalence, incidence, and residual risk of human immunodeficiency vir us among community and r eplacement f irst-time blood donor s in S\u00e3o Paulo, Brazil. Transfusion 2005; 45:1709-14. Barsoum RS. Parasitic HTLV F, M osca M. The risk of contracting an i nfectious dise ase from blood transfusion. Transplant Proc 2004; 36:680-2. Degertekin B, Lok AS. Opin Gastroenter ol 2008; 24:306-11. Hematol 2007; 14:671-6. Feder Shapiro ED, Steere AC, Wormser GP, and the Ad Hoc International Lyme Disease Group. A critical appraisal of \"chronic Lyme disease\". N Engl J Med 2008; 357:1422-30, Fenollar F, Raoult D. Molecular diagnosis of bloodstream infection caused by non-culti vable bacteria. Int J Antimicrob Agents 2007; 30S:S7-15. WW, Gallego S. ogy 2008; 371:550-9. Gubler DJ. The continuing spread of West Nile virus in the Western Hemisphere. Clin Infect 2008; 37:161-72. Komar N, Clark GC. West Nile virus activity in Latin America and the Caribbean. Rev Panam Salud recipients. Clin Infect Dis 2007; 44:857-66. Leiby DA, Gill JE. Transfusion-transmitted tick-borne infect ions: a cornucopia of threats. Transfus Med Rev 200 4; 18:293-306. Leiby DA. Threats to blood safe ty posed by emerging protozoa n pathogens. Y Acad Sci 2005;1054:325-41. MacPherson IK. Verses, viruses, and the vulnerability of the blood supply in industrialized countries. J Med VIrol 2007; 79:1229-37. O'Brien SF, QL Yi, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Current incidence and estimat ed residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007; 47:316-25. Peters T, Mohr L, Scheiffele F, Schlayer HJ, Preisier S, Berthold H, Gerok W, Rasenack J. Antibodies and viremia in a cute post-tra nsfusion hepatitis C: J Med Virol 1994; 42:420-7. Procop GW. Molecular diagnostics Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I and associated diseases. Oncogene 2005; 24: 6058-68. Smith JM, ald Transplant 2006; 10:838-43. Soldan K, Davison B. Estimates of the frequency of HBV, HCV, and HIV i nfectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveill 2005; 10:17-9. Stramer SL. Current risks of tran Arch Pathol Lab Med, 2007; 131: 702-7. Tapper ML. Emerging viral diseases and infectious risks. Haemophilia 2006; 12 (Suppl 1) : 3-7. Vamvakas EC, Kleinman S, Hume H, Sher GD. The development of West Nil e virus safety policies by Canadian Blood Ser vices: guiding principles and a comparison between Canada and the United States. Transfus Med Rev 2006; 20:97-109. Zou S, Fang CT, Schonberger Transfusion transmi Transfus Med Rev 2008; 22: 58-69. Zou S. Potential impact of pan demic influenza on blood safety and availability. Trans Med Rev 2006; 20: 181-9.54 Recomendaci\u00f3n de diferimiento donantes las que ser trav\u00e9s de diferentes poblaciones, caracter\u00edsticas los del Nilo Occidental (West Nile Virus en ingl\u00e9s) en el an\u00e1lisis.BABESIOSIS La babesiosis es una zoonosis que se mantiene un r SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Sem Hematol 2007; 44:32-41. Babu RV, Sharma G. A 57-year-old man with abdominal pain, jaundice, and a history of blood transfusion. Chest 2007; 132:347-50. Cable RG, Leiby DA. Risk and prevention Ahmed A, Arnold A, Chou J, Rhe in L, Levy O. Neonatal babesiosis: case report and review of the literature. Pediatr Infect Dis J 2006; 25: 169-73. Kjemtrup AM, Lee B, Fritz CL, Evans Chervenak M, Conrad PA. Investi gation of transfusion transmissi on of a WA1-type babesial parasite to a premature infant in California. Transfusion 2002; 42:1482-7. Krause PJ. Babesiosis. Med Clin North Am 2002; AP, Badon S, Cable RG. Demonstrable with Babesia microti. Transfusion 2005; 45:1804-10. Leiby DA. Babesiosis and blood transfusion: flying u nder the radar . Vox Sang 200 6; 90:157-65. Linden JV, Wong SJ, Chu FK, Schmidt GB, Bianco C. Transfusion- associated transmission of babesi osis in New York Stat e. Transfusion 2000; 5-9. Pantanowitz L, Aufranc Transfusion portan Brucella dos Brucella melitensis in blood cultu res of two newborns due to exchan ge transfusion. Turk J Pediatr 2005; 47:272-4. Baldwin CL, Goenka R. Host immune responses to the intracellular bacteria Brucella: does th e bacteria instruct the host facilitate infection? isolation Brucella melitensis biovar 3 from human breast milk. Scand J 39:205-8. BG, Amarnath SK, Shinde Review of clinical and laboratory features of human brucellosis. Indian J Med and blood transfusion: case report and of the literature. Ann Trop Paediatr 2001; 21:349-52. Mendoza Nu Abdoel KL and the Brucellosis Working Group in Callao. Brucellosis in houselhold members of B rucella patients residing in a large urban setting in Peru. Am J Trop Med Hyg 2008; a national serological survey for diseases transmitt ed by blood por exposici\u00f3n a aerosoles contaminados producidos por la tos y del contacto con supercies contaminadas r enfermedades leves donaci\u00f3n. 56 Recomendaci\u00f3n de l a OPS: individuos a Bibliogr\u00e1ficas Eccles, R. Mechanisms of symptoms of the common cold and i nfluenza. Br J Hospit Med Rhinovirus the normal hu man airway. Am J Respir Crit Care Med 1995; 52:S36-9. Harris JM Jr. Incubation periods of experiment al rhinovirus infection and illness. Cl in Infect Dis 1996; 23:1287-90. Page CL, Diehl JJ. Upper respiratory tract infections athletes. Clin Sports Med 2007; 26:345-59. Roxas M, Jurenka J. Colds and influenza: A review of diagnosis a nd conventional, botanical and nutritional cons iderations. Alter Med Rev 2007; 12:25-48. DENGUE El dengue infecci\u00f3n a humanos por la picadura de mosquitos infectados con el virus. La exposici\u00f3n de los trabajadores de la salud a del virus, es end\u00e9mico en m\u00e1s de 100 pa\u00edses - en Africa, las Am\u00e9ricas, el este del Mediterr\u00e1neo, el Sudeste asi\u00e1tico infecci\u00f3n adquirida puede transmitirse con cual comienza el d\u00eda al momento de la donaci\u00f3n. No hay ni tratamiento antiviral ni vacunas espec\u00edcas contra el dengue. diferir donantes con Rocha J, P\u00e9rez MA, Silva S, Rocha C, Harri s E. Serotype- specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 2006; 74:449-56. and Chikungunya KT, Leong TY, Tan PH, Wannakrairot P. The Lee T- H, Kolk AS, Collins CS, Lanciotti RS, Busch MP. Dengue viremia in blood donors from Honduras, Brazil, and Australia. 2008; 48:1355-62. Mohammed H, Linnen JM, Mu\u00f1oz-Jordan Broulik AS, Petersen L, Stramer SL. Dengue virus in blood donations, Puerto Rico, 2005. Transfusion 2008; 48: 1348-54. Nishiura H, and DENV-4 of Dengue Med causa de da\u00f1o hep\u00e1tico n todo el mundo son las infecciones. Las infecciones por hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E, herpes simplex, citomegalovirus, virus ingesti\u00f3n de agua contaminadas con hece C transmitirse de las relaciones sexuales con personas infectadas. La hepatitis B - en conjunci\u00f3n con la hepatitis D - y los virus de la hepatitis C pueden hepatitis B seis meses. Pareja sexual actual de un pacie nte con hepatitis B o C. AABB: diferimiento por una persona con hepatitis B. diferimiento por JM, Rivero RA, Villaescusa R, Merlin RM, Ballester A, Almaguer M, Melians SM, Aparicio JL. Hepatitis C virus antibodies and other markers of blood-transfusion-transmitted infection in multi-transfused Cu M, J aramillo S, Estrada C, Del Pilar Cortes L, Arbalaez MP, Donado J, Barco G, Lu na M, Uribe GA, de Maldonado A, Restrepo JC, Correa G , Borda P, Rey G, de Neira M, Estrada S, Beltran O, Pacheco J, I, Boshell J. Hepatitis C virus seroprevalence in multi-transfused Sherman Virus Infection: A Chronic Pr oblem. Hepatology 2008; 47:321-3 1. Blessman DJ. Chronic hepatitis C in the Hispanic/Latino population living in the United Stares: a literature Nurs DM. in health care professionals: prevalence and as sociation wit h risk factors. Rev Saude Publica 2007 41(2):229-35. Cruz JR, P\u00e9rez-Rosales MD, Zicker F, Schmunis GA. Safety of blood supply in the Caribbean countries: r ole of screening blood donors for markers of hepatitis B and C viru ses. J Clin Virol 2005; Jr, Sim\u00e3o Ferreira M, Focaccia R, Pawlotsky J-M, and Brazilian Society of Infectious Diseases HCV Consensus Group. Consensus of the Brazilian Society for Infectious Diseases on the Management and Treatment of Hepatitis C. Braz J Inf ect Dis 2007; 2005; 34 Suppl 2:S27-32. Gast roenterol 2008; 24:306-11. Hollinger FB. Hepatitis B infection and transfusion medi cine: science and the ocult. Transfusion 2008; 48:1001-26. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok ASF. Managem ent of hepatitis B: Summary of a Clinical Research Workshop. Hepatology 2007; 45:1056-75. Kamal SM. Chunga Flores W, Retamal A, Mendoza S, Cruz M, Monge Z, Lava lle M, Gutierrez J, Malaga J, Soto E, Loayza N, Bolivar D, Reyna R, ections among multi- transfused patients in seven J Clin V irol 2005; 34 Suppl 2:S61-8. Lopez L, Lopez P, Arago A, Rodr\u00edguez I, Lopez J, Lima E, Insagara y J, Betancor N. Risk factors f or hepatitis B and C in mult i-transfused patients in Luban NLC, Colvin P, Alter HJ. The epidemiology o f transfusion-associated hepatitis C in a children's hospital. Transfusion 2007; 47:615-20. Mast EE, Weinbaum CM, Alter BP , Finelli L, Rodewald LE, Douglas JM, Janssen RS, Ward JW. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. MM WR 2006; 55:1-25. McMahon BJ. Natural history of chronic hepatitis B -Clini cal implications. Medscape J Med 2008;10:91-100. Medline Plus. Hepatitis. tis.html. Consulted July potenciales con historia hepatitis B o C deben ser diferidos en forma permanente. Los que han estado expuestos a individuos con hepatitis B o C por de y deben diferidos durante meses. A las realicen pruebas B y C. Los sistemas de salud deben prom over la vacunaci\u00f3n universal contra la hepatitis B de los infantes, de los trabajadores de la salud, y de quienes conviven con enfermos con hepatitis en conductas riesgo. AA, Liang TJ. Hepatitis C: a clinical review. Oral Diseases 2008; 14:10-4. National Digestive Diseases Information Clearinghouse (NDDIC). Viral hepatitis: A through E and beyond http://digestive.niddk.nih.gov/ddiseases/pubs/rialhepatitis. Consulted 3 1 July 2008. Neaigus A, Gyarmathy VA, Filler M, Frajzyngier V, Zhao M, Friedman SR, Jarlais DC. Injecting and sexual correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend 2007; Feb 6 published ahead of print. Neaigus A, Gyarmathy VA, Zhao M, Friedman SR, Des Jarlais DC. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin J Infect Dis 2007; 195:1052-61. Oldfield EC, Keefe EB. The A's and B's of vaccine-preventable hepatitis: Improving prevention in high -risk adults. Rev Gastroenterol 2007; 7:1-21. Peters T, Mohr Preisler S, Berthold H, Gerok W, Rasenack J. Antibodies and vir emia in acute post-tra nsfusion hepatitis C: a prospective study. J Med Virol 1994 ; 42:420-7. Prati D. Transmission of hepatitis C virus by blood tr ansfusions and other medical procedures: A global r eview. rlander Larsen Lot F, Lunding S, Marcus U, Payne L, Pereira AA, Thomas T, Ippolito G, The European Occupational Post-Exposure Prophylaxis Study Group. Europe an recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill 2005; 10:260-4. Remesar S, Perez-Bianco R, Manterola A, Del Pozo A. Antibodies to hepatitis C and other viral markers in multi-transfused patients from Argentina. J Clin S, Perez-Bianco R, Manterola A, Del Pozo A. Antibodies to hepatitis C and other viral markers in multi-transfused patients from Argentina. J Clin Virol 2005; 34 Stramer SL. Arch Pathol Lab Med a ssociated with HIV and HCV in fection in female prison inmates in Sao Paulo, Brazil. Cad Saude Publica 2007:197-205. Tuke PW, Grant PR, Waite J, Kitchen AD, Eglin RP, Tedder RS. Hepatitis C virus window-phase infecti ons: closing the window on hepatitis C virus. Transfusion 2008; 48: 594-600. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW. Recommendations for Identification and Public Healht Management of Persons with Chronic Hepatitis B Virus Infections. MMWR 2008; 57:1-20. Whitlock M, Lord S, Buxton JA, Doyle P, Bigham M. Evaluating the impact of public health noti fication of suspected transfusi on- transmissible hepatitis C virus infection and effectiveness of lookback and traceback investigatio ns by Canadian Blood Services in British Columbia, Canada, August 2002 through February 2005. Transfusion 2007; 47: 1534- 9. Wikipedia, the free encyclopedia. Hepatitis. http://en.wi kipedia.org/wiki/hepatitis. Consulted 31 July 2008. World Health Organization. Hepatitis B. Fact sheet No 204, Revised August 2008 http://www.who.int/mediacentre/facsheets/fs204/en/print.html. Consulted 26 August 2008. Yiu-Kuen But D, Lai C-L, Yuen M-F. Natural history of hepatocellul ar carcinoma. J G astroenterol 2008; 14:1652-56. VIRUS DE LA INMUNODEFICIENCIA HUMANA la Regi\u00f3n de las Am\u00e9ricas es, para la parte de la leche materna, y por con El virus ataca sistema inmunol\u00f3gico que lo vulnerable infecciones secundarias y oportunistas y tir el VIH y otras sexual pasada de persona con o con alto riesgo de infecci\u00f3n por Valde rrama JA, Macias AE. H IV in Mexican blood donors and esti transfusional risk. Rev Invest Clin 2008; HIV/AIDS interventi ons in Africa: a systematic review of the evidence. Lancet 2002; 359:1635 Gendler SA and MS Pascuccio. Routine HIV screening among blo od donors in Buenos Aires (Argentina). Results f rom six years' experi ence McFa rland W. Human immunodef iciency virus test-seeking motivation in blood donors, S\u00e3o Paulo, Brazil. Vox Sang 2006; 90:170-6. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2006 Report on the global AIDS epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2006 AIDS epidemic update, December 2006. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2007 Re port on the global AIDS epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS). 200 7 AIDS epidemic update, December 2007. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2008 Report on the global AIDS epidemic. November 2008. Le\u00f3n G, Hern\u00e1ndez T, Quiros AM, Maio A, Garc\u00eda L. How to reduce the prevalence of HIV-positive blood donors. Inves t Clin 1998; 39: 307 -21 . Spada C, Souza MA, Treitinger A. Estimation of the residual ris k for the transmission of HIV in blood donors f rom the Mountain Region of Santa Catarina. Braz J Infect Dis end\u00e9micas del mundo incluyen Latinoam\u00e9rica Chile Uruguay) del Sur, el Medio Oriente, el norte y El per\u00edodo promoci \u00f3n de pruebas v oluntarias en lugares de los servicios de sangre.CoE requiere mucosa l leishmaniasis in Lat in America: Systematic Review. Am and prospect s for treatment. Act Trop 2008; 105:1-9. Antinori S, Gianelli E, Corbellino 2005;11: 343-6. Imbert P , Garrab\u00e9 E, Debord T, and Spiegel A. Outbreak of cutaneous l eishmaniasis in military population coming back from Sante Publique 2006; 54:213-21. Cardo the blood supply. Transfusion 2006; 46:1641-5. Centers for Disease Control and Prevention. Leishman ia infection (leishmaniasis). http://www.cdc.gov/ncidod/dpd/parasites/leishma nia /factsht_ leishmani J, Boelaert M. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 2007; geli D, Borges R, Rodriguez N. The epidemiology and control of leishmaniasis in Andean countries. Cad Saude Publica Singh S. Trasfusion transmitted leishma niasis: case report and review of the literature. Indian J Med Micr obiol 2006; 24:165-70. Mathur P, Palatnik M, Pirmez C, Fernandes O, Sousa CB. Short Report: Occurrence of leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors. Am J Trop Med Hyg 2000: 62:128-131. Reithinger R, Dujardin J-C. Molecular diagnosis J Clin Microbiol 200 45: nez Sede\u00f1o M, Mascaro M, Udina M, Gallego M, Carr io Forteza A, Portus M. Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). 2008; 48:1383-9. matic Leishmani a infantum/chagasi infection in blood donor s of Western Sicily. Trans Roy Soc Trop Med Hyg 2008; 102:394-6. Wagner SJ, Skripchenko a donovani infantum and Trypanosoma red 2008. World Health Organization. Leishmaniasis. http://www. who.int/topics/leishmaniasis/en. Consulted 8 September 2008. MALARIA La malaria es una enfermedad causada por el Plasmodium , un par\u00e1sito humanos por excepci\u00f3n de Chile y Uruguay . La mayor\u00eda de los casos en la Regi\u00f3n ocurren en estos En los casos falciparum .62 Recomendaci\u00f3n h\u00edgado por per\u00edodos tiene la M\u00e9xico y Am\u00e9rica Central es susceptible a la cloroquina, que es la droga antimal\u00e1rica de uso de su pol\u00edtica en drogas Combinaci\u00f3n Terapias para y total recuperaci\u00f3n. AABB, ARC, CoE y CRS t ienen los siguientes Individuos que han menos cinco a\u00f1os consecutivos en un cons iderada end\u00e9mica. AABB Bibliogr\u00e1ficas Alkassab Prenventa tive Measures? Am J Med 2006; 119:e1-2. Centers for Disease Control and Prevention. Malaria. http:/ /www.cdc.gov/malaria/disease.htm Consulted 9 September 2008. Contreras CE, Pance A, Marcano N, Gonzalez N, Bianco N . Detection of specific antibodies to Plasmodium falciparum in blood bank donors from malaria-endemic and non-endemic areas of Venezuela. Am J C, of the DiaMed enzyme-linked immunosorbent assay malaria antibody tests for screening blood donors for mala ria. Vox Sang 2008; 94: 33-40. Freeman DO. Malaria p revention Ma roso RD, Am sp asymptomatic carriers among transfusion cente rs from Brazilian Amazon Region. Rev Inst Med Trop Sao Paulo 2007; 49: G, Elghouzzi A, David B, Joussemet M, de Micco P. Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang 2008; 95: 226-31. Greenwood BM, Fidock DA, Kyl e Alonso P L, Collins FH, Duffy PE. Malaria: progress, perils, and prospects for eradication. J Clin Invest 2008; 118:1266-76. Katz LM, Kabat A. Return behavior of blood donors after expiration of a 1-year malarial travel deferral. Transfusion 2007; 47: 356-7. Kitchen AD, blood ion. Vox Sang 2006; 90: 77-84. Kitchen A, Mijovic A, Hewitt P. Transfusion-transmitted malaria: current donor selection guidelines are not sufficient. Vox San g 2005; 88:200-1. Kitchen AD, Barbara JA, Hewitt PE. Documented ca ses of post-transfusion malaria occurring i n England: a review in relation to curren t and proposed donor-selection guidelines. Vox Sang 2005; 89:77-80. Leiby DA. Making sense of malaria. Transfusion 2007; 47: 1573-7. Leiby DA, Nguyen ML, Norati EP. Impact of donor deferral s for malaria on blood availability in the United States. Transfusion 2008; 48: 2222-8. Maalouf N, Naja Taher A. Transfusion-transmi tted malaria: how vital is the need countries? Transfusi on-transmitted malaria in the United States f rom 1963 th rough 1999. N Engl J Med 2001; 344:1973-8. Price RN, Tjitra E, Guerra Yeung S, White NJ, Ans tey NM. Vivax malaria: Neglected and Not Benign. Am J Tr op Med Hyg 2007; 77(Suppl 6):79-87. S\u00e1ez-Alqu\u00e9zar A, Ramos Kirchgatter K, Cordeiro MG, Pirolla JA, Guerzoni D, Chamone DA. Control of blood transfusion malaria in an endemic and in a non-endemic r egion in Brazil. Rev Soc Bras Med Trop 1998; 31:27-34. Thwing J, Skarbinski J, Newman RD, Barber AM, M ali S, Roberts JM, Slutsker L, Arguin PM; Centers for Disease Contr ol and Prevention. Malaria Surveillance - United States, Surveill WH. A Review of Malaria Diagnostic Tools: Microscopy and Rapid Diagnostic Test (RDT). Am J Trop Med Hyg 2007; 77(Suppl 6) 119-27. World Health Organization. Fact sheet No. 94. Malaria . http://www.who.int/mediacentre/factsheets/f s094/en/print.htlm Consulted 9 September de mosquitos infectados de los donantes de gre, es esencial los servicios de dispongan por una bacteria, el pallidum La transmisi\u00f3n se produce durante el sexo anal u oral. Entre 9 y de infecci\u00f3n aparece tratamiento, la bacteria permanece generalizada incluye las plantas de los pies, las p almas de las manos y el cuero cabelludo. Si aplica tratamiento, los s\u00edntomas de la infecci\u00f3n desaparecen por un puede de a tempe raturas y por lo tanto no se transmite por la sido almacenada entre 4-6\u00baC durante de 72 hrs. Sin la transmisi\u00f3n de la transfusi\u00f3n de plaquetas es 12 meses. Referencias Bibliogr\u00e1ficas Azaria S, Perkins N, Austin P, Morris AJ. Increase in incidence of infectious syphilis in Auckland, New Zeland: results from an enhan ced surveillance survey. Sex e in recently acquired syphilis infections in English, Welsh and Nor thern Irish blood donors. Vox Sang 2007; 93:19-26. Chakraborty R, Luck S. Syphilis is on the increase: the implicat ions for child health. Arch Dis 93: Clark J, Konda KA, Munayco Leon J, Suarez-Ognio L, Klausner JD, TJ, Herpes Simplex Virus-2, and Syph ilis in male sex partners of pregnant wom en in Peru. BMC Public H ealth 2008; 8:65. Eccleston K, Collins STD&AIDS 2008; , Aral S, Blower S. Infectious syphilis in high-income settings in the 21st century. Lancet Infect Dis 2008; 8:244-53. French P. Clinical Review. Syphilis. BMJ 7. Kent syphilis: an update on epidem iology, clinical manifestations, and manage ment. Ann Pharmacother 22 6-36. Lautenschlager S. Diagnosis 4: Prat I, Cabezos J, Mongui E, Claveria I, Luis del Val J, Zabaleta E, Zarzuela FA, Navarro R. Com municable diseases in the immigrant population attended to in a tropical medicine unit: epidemiological aspects and public health issues. Travel Med Infect Dis 2008; 6: 4-11. Oncul O, The sixteen-yea r trend of syphilis in Tur key: data from donors. 38: L, Diagn\u00f3sti co microbiol\u00f3gico de las evidencia HIV-1, HSV-2 and syph ilis among pregnant women i n a rural area of Tanzania: prevalence and risk factors. BMC Infect the United States: an update for clinicians with an emphasis on humanos. ana son la ingesti\u00f3n de par\u00e1sitos, la trasplacentaria la madre de lechos de arena usados para grandes cantidades de par\u00e1sitos infectados en sus por lo que juegan un papel im portante en la habitualmente leve o de la madre Seroepidemiology o f infection with Toxoplasma gond ii in healthy blood donors of Durango, Mexico. BMC Infect Dis 2007; 7:75. Assi MA, Marshall WF. Donor-transmitted toxoplasmosis in liver transplant recipients: a case report and literature review. Transpl Infect Dis 2007; 9: 132-6. Centers for Disease Control and Prevention. Toxoplasmosi s. http://www.cdc.gov/toxoplasmosis Consulted 24 September 2008. Cochrane Collaboration. Management of toxoplasmic ence phalitis in HIV-infected adults (with emphasis settings) (Review). The Cochrane Library 2008; 3:1-15. Published by John Wiley& Sons, Ltd. Co\u00ealho RA, Kobayashi M, Carvalho LB Jr. Prevalence of I gG antibodies specific to Toxoplasma gondii among blood donors in Recif e, Northeast Brazil. Rev Inst Med Trop Sao Paulo 2003; 45:229-31. Elsheikha HM. Congenital toxoplasmosis: Priorities for further health J Royal Inst Pub Health 2008; 122: 335-53. Galvan Ramirez ML, Covarrubias Rodriguez R, Alfaro N, Correa D. Toxoplasm a gondii antibodies in Mexican blood donor s. Transfusion 2005; 45: 281-2. McDonald CP, Barbara JA, Contreras M, Brown S. Provision of a panel of anti- Toxoplasma -negative with International Tr avel During Pregnancy. Med 2007; D. Problems and limitations of conventiona l and innovative methods for the diagnosis of Toxoplasmosis in humans and animals. Parassitologia 2004; 46:177-81. Rabinowitz PM, Gordon Z, que tengan anticuerpos r SK. Toxoplasma seroprevalence in healthy voluntary blood donors from urban Karnataka. Indian J Med Res in the blood supply: assessi ng and threat. 24 September 2008. Yazar Eser B, Yay M. Prevalence of anti- Toxoplasma gondii antibodies in Turkish blood 44: 257-61. Zarkovic A, MacMurray C, Deva N, Ghosh D, Guest S. Seropositivity rates for Bartonella henselae, Toxocara ca nis and e el a carne dando lugar a de acumularse 14:210-4. Di sease. Rev Public Health 2005; 26:191-212. Brown P. Creutzfeldt-Jakob Disease: reflections on the blood product therapy. Haemophilia 2007; 13(Suppl 5):33-40. Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances. CNS Drugs 2006; 20:15-28. Centers for Disease Control and Preve ntion. Office of Health a nd Safety. BMBL Section Summar y Statements. Section VII- D: Prions. http://www.cdc.gov/od/ohs/biosf ty/bmbl4/bmbl4s7d.htm Consulted 10 September 2008. Clarke P, Will RG, Gha ni AC. Is there the potential f or an epidemi c of variant Creutzfeldt-Jakob disease via blood transfusion in the UK? J R Soc Interface 2007; 22; 675-84. Dietz H-P, Levef re H, Seifried E, Lower J . Blood Transfusion and Spread of Variant Creutzfeldt-Jakob Disease. Dis 2007; 529:17-21. Flan B, Arrabal S. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: Precautionary measures and efficacy of manufacturing processes in Transfusion Clin Biol 2007; Creutzfeldt-Jakob disease and blood transfusio n: results of the UK. Tra nsfusion Medicine Epidemiological Review study. Vox Sang 2006; 91:221-30. Jorquera JI. Safety procedures of Am J Pathol 2008; 172:555-65. Krasnianski A, Bard M, Sanchez Juan PJ, U, Meis sner B, Varges D, Schultze-Sturn U, WJ, Zerr I. Fatal Familiar Insomnia: Early Identification. Am Neurol Asssoc 2008; 63:658-61. Lumley JSP. The impact of Ann Definition of Gerstmann-Strausse-Schinker Syndrome. http://www.medterms.com/script/main/art.asp?articleley+25941 Consulted 10 September 2008. Ponte ML. Insights into the management of emerging infections: r egulating variant Creutzfeldt-Jakob disease tr ansfusion risk in the UK and the US. PLoS Med 2006; 3:e342. de heredar TSE humana, que tienen riesgo de haber adquirido la vCJD transfusiones Ryou C. Prions R, Dietz V, Volkers P, of vCJD on blood supply. Biologicals 2007; 35:79-97. Turner M. Trans fusion safety with regards to prions : ethical, legal and societal considerations. dental practitioners? Prim Care 2002; 9:95-9. Wikipedia, the free encyclopedia. Prion. http://en.wikipedia.org/wiki/Prion S, LB. Transfusion transmi enfermedad parasitaria que tiene lugar en la mayor parte de las Am\u00e9ricas, desde el sur de los Estados Unidos hasta Argentina Chile. El T. cruzi, su etiol\u00f3gico, es transmitido a los bug en fases: la aguda, que se produce corto tiempo despu\u00e9s de la infecci\u00f3n y la cr\u00f3nica. La mayor parte de las infecciones agudas son subcl\u00ednicas. Entre el 5% y LV. Use of a questi onnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi MJ. Control of Trypanosoma cruzi infection in blood donors in Colombia, 2003. Biomedica 2005; 25:527-321. Castro JA, de Mecca MM, Bartel LC. Toxic side effects of drugs used to treat Chagas' disease (American tr ypanosomiasis). Hum Exp Toxicol 2006; 25: 471-9. Centers for Disease Control and Prevention. Blood donor screening for Chagas disease -United States 2006-2007. MMWR 2007; 56:141-3. Centers for Disease Control and Prevention. Chagas Disea se after organ transplantation -Los Angeles, Calif potenti al for emergence of Chagas disease in the United States. Geospat Health 2008; 2: 227-39. Comit\u00e9 de de Chagas en donantes de banco de sangre. in Brazil. BMC que familia del -Yasuda MA, Aras R. Acute Chagas disease outbreak associated with oral transmission. Ver Soc Bras Med Trop 2008; 41: 296-300. Diaz JH. Recognizing and reducing the risk of Chagas disease (American trypanosomiasis) in travel ers. J Travel Med 2008; 15: 184-95. Flores-Chavez M, Fernandez B, Puente S, Torres P, Rodriguez M, Mon edero C, Cruz I, Garate T, Ca\u00f1avate C. Transfusional Chagas Disease: Parasitological and Serological Monitoring of Donor. Clin Infect Dis 2008; Olivera Vasconcelos M, Janczuk D, de Souza Mar tins C. Sequence of unusual Chagas infection transmissions in the same family: mother by blood transfusion and child congenitally, with a treatment- resistant strain of Trypanosoma cru zi Rev Measures to prevent transfusion-assoc iated protozoal infections in non- endemic areas. Travel Med Infect Dis 2007; 5: 110-2. Galaz P, Garcia S, Mercado R, ontreras L\u00f3pez Cardenas M, Reyes PA, Hirayama K, Monte\u00f3n VM. Blood transfusion and iatrogenic in Mexico City. Anti- Trypanosoma cruzi seroprevalence in 43,048 blood donors, Mem 111-6. Jaramillo R, Bryan J, Pan AA. Prevalence of antibody to Trypan osom a cruzi in three populatio ns in J Trop Med Hyg 1997;57: 298-30. Kirchhoff disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 2006; 46: 298-304. Kjos SA, Snowden KF, Olson Trypanosoma cr uzi Infection Prevalence of Chagas Disease Vectors in Te xas, USA. Vector Borne Zoonotic Dis 2008; Epub ahead of print. Leiby DA, G, Herwald BL. Trypanosoma c ruzi Parasitemia in US Blood Donors with Serologic Evidence of Infection. J Infect Dis 2008; 198:609-13. Leiby DA, Herron RM Jr, Read EJ, Lenes BA, Stumpf RJ. Trypanosoma cruzi in Los Angeles and M iami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion Danis Pialoux An update on Chagas disease (human American trypanosomiasis). Ann Trop Med Parasitol 2006; 100: 663-77. O'Brien SF, Chiavetta JA, Fan W, Xi G, Yi Q-L, Goldman M, Scalia V, Fearon MA. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi : operational validity and field testing. Transfusion Piron cruzi 2008; 48: 1862-8. G, Gowd a RM, Khan IA, Navarro VS, Vasavada BC. Clinical aspects of the Chagas heart Int antibodi es against Trypanosoma cruzi in blood bank donors from the IMSS General Hospital in Orizaba, Chamone DF. Trends in the prevalence of Chagas' disease among f irst-time bloo d donors in S\u00e3o S\u00e1nchez Negrette Basombrio MA. High of congenital Trypanosoma cr uzi infection and family clustering in Salta, Argentina. Pediatrics 2005; 115:e668-72. Schmunis GA. Epidemiology of Chagas disease in non-endemi countries: the role of international Cruz 2007; 102 (Suppl disease. Series 2007; antibodies to Trypanosoma cruzi in Latin American refugees and immigrants to Canada. J Immigr Minor Health 2007; evel of congenital Trypanos oma cruzi infection in the areas of maternal residence and the development of congen ital Chagas disease in Bo livia. Rev Soc Br as Med Trop 2005;38 Suppl implementation methods for ELISA serology testing of Trypanosom a cruz i in California Blood Banks. Am J Trop Med Hyg 2008; 79: in the sur gical patient and increased susceptibility to infection. Cr itical Care 2002; 6:298-305. Choileanin, NN, Redmond 1132-40. S67-70. Klein HG, Spahn DR, Carson JL. Red blood cell in 370: M, Yasuda M, Rakawa S, M onden K, Japanese Society of UTI Cooperative Study (Chairman; T. Matsumoto). Japanese guidelines for prevention of perioperative infections urological d. Biedler A, Silomon M. Proc alcitonin plasma concentrations and systemic inflammatory response following different types of surgery. Anaesthesist 2003;52:210-7. al joint arthroplasty: When do fatal or near-fatal complications occur ? J Bone Joint Surg Am 2007; Rowley Mart\u00ednez C. Preopera tive hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone J oint Surg Am 2002;84-A(2):216-20. Slinger A. Current status of bacterial contamination of autologous blood for trans fusion. Transfus Apher Sci personas han recibido a partir 1980 se n los Las personas han Europa Occidental desde el 1ro. G, Frohlich L, Bennet CL. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia. Vox Sang 2007; 93:159-65. Busch MR. Evolving approaches to estimate risk of transfusion-transmitted viral infections: Incidence-window period model after ten years. Dev (Basel) 127: 87-112. Cruz JR, Perez-Rosales MD, Zicker F, Schmunis GA. Safety of the blood supply in the Caribbean countries: role of screening blood donors for markers of hepatitis B and C viruses. J Clin Virol 2005; 34 (Suppl 2): S75-80. Cruz JR, Perez-Rosales MD. Availability, safety and quality of blood for transfusion in the Americas. World Hosp Health Ser v 2005; 41: 27-31. 263-78. Prati D. Transmission of hepati tis C virus by blood tra nsfusions and other medical procedures: a global view. J H epatol 2006; 45: 607-16. Schmunis GA, Cruz JR. Safety of the blood supply in Lati n America. Clin Microbiol Rev 2005; a review. Arch Pathol Lab Med Heikkila JT, Meurman O. Bone bank service in Finland. Experience of bacteriologic, serolo gic and clinical results of the Turku Bone Bank 1972-1995. Acta Orthop Thorac Soc Galea Comparison of valence rates of microbiol ogical markers between bone/tissue donati ons and new blood do nors in Scotland. Vox Sang 2006; 91:28-33. Kumar D, Humar 2005; 18:337-41. Kalligonis AN, Rat ner LE. Expanded criteria donors: attempts to increase th e renal transplant donor pool. Adv Ren Replace Ther 2000;7: 117-30. Silveira FP, Husain transplantation. Med Mycol 2007; 45:305-20. Triulzi DJ. Specialized transfusion Los vez y los adolescentes se han se\u00f1alado los Bibliogr\u00e1ficas France CR, Rader A, Carlson B. Donors who react may not come back: analysis of repeat donation as a function of phlebotomist ratings of vasovagal reactions. Transfus Aphe r Sci 2005; 33:99-106. Newman BH, Newman DT, Ah mad R, Roth AJ. The effect of whol e-blood donor adverse events on blood donor return rates. Transfusion 2006; 46:1374-9. Recomendaciones para la los donante han en l Pichette S, Pichette D, Dzaka E. Adverse effects in blood donors after whole-blood donation: a study of 1,000 blood donors interviewed 3 weeks after whole-blood donation. Transfusion 2003; 43:598-603. Newman B, Tommolino E, Andreozzi C, Joycahn Heringhausen J. effect of 473-mL ( 16-oz) water drink on vasovagal donor students. Transfusion 2007; Popovsky Shehata N, Kusano R, Hannach B, 2004; 14:327-33. Sorensen BS, Johnsen J. Complications related donation: a population-based study. Vox Sang 2008; 94: 132-7. France CR, Rader AW, Stewart JC. Phleb otomist interpersonal skill predicts a reduct ion in reactions among volun teer blood donors. Transfusion Lu A, Goldfi nger D. Risk factors for acute, moderate to sever e donor reactions associated with multicomponent apheresis Tzolou A. Vasovagal reactions in blood donors during and immediately af ter blood donation. Transf libertad. Referencias Bibliogr\u00e1ficas Blick JA. Infection control in and prisons. Cli n Infect Dis 2007; 45: 10-47-55. Butler T, Boonwaat L, Hailstone S. The 2004 Australian pri sons entrants' blood-borne virus and risk behaviors survey. Aust NZ 2007; Pedr al-Sampaio D, Ramos M, Britres C. Prevalence and risk of blood-borne and sexually transmitted viral infections in incarcerated youth in Salvador, Brazil: opportunity and obligation for intervention. AIDS Behav 2008; 12 in prisons -not such Aust J Infect Control 2007; 35: 47-80. Hennessey KA, Kim AA, Griffin V, Collins NT , Weinbaum CM, Sabin K. Prevalence of infection with hepatitis B and C viruses and co- infection with HIV in three jails: A case for viral hepatitis prevention in jails in the United States. J Urban Health 2008; Epub ahead of print. 2008. Kanat M. Drug use and health among prison inmates. Curr Opin Psychiatry 2008; 21: F, Leo G, budieri Starnini G, Monarca R, Suligio B, Rezza G, Ciccozzi M. Italian Group on HIV in Prison. HIV-1 diversity among inmates in Italian prisons. J Med VIrol 2008; 80:1689-94. Main CL, F, F Outbreaks infection caused by com munity-acquired methicillin- resistan Staphylococcus aereus in a Canadian correctional facility. J Infect Dis Med Microbiol 2005; 16: 343-8. McGovern B. A golden opportunity: of he patitis C in HIV-infected inmates , J Addict Dis 2008; 27: 69-73. Mor Z, Adler A, Leventhal A, Volovic I, Rosenfeld E, Lobato MN, Chemtob D. Tuberculosis behind bars in I srael: policy making within a dynamic situation. Isr Med Assoc J 20 08; 10:202-6. Murray E, Jones D. Audit into blood-borne virus services i n Her Majesty's Prison Service. Int J STD AIDS 2008; 19:347-8. Pontali E, Ferrari F. Prevalence of hepatitis B virus and/or hepatitis C virus co-infections in prisoners infected with the human immunodeficiency virus. Int J Prison He alth 2008;4:77-22. Sifunda S, Reddy PS, Braithwaite R, Stephens T, Bhengu S, Ruit er RA, van den Borne B. The effectiveness of peer-led HIV/AIDS and STI health education intervention for prison inmat es in South Africa. Health Educ Behav 2008; 35:494-508. Tuli K, Kerndt PR. Preventing sexually transmitted infect ions among incarcerated m en who have sex w ith men: a cost effectiveness analysis. Sex Transm Dis 2008; Epub ahead of print 1 October 2008. Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R. Correlates of hepatitis C virus seropositivity in prison inmates: a HL. H ealth and health behaviors in HIV-infected inmates, 1999 and 2005. AIDS Patient Care STDS 2008; 221-31.76 voluntario de detecci\u00f3n B y C, y otras para la Educaci\u00f3n DE LOS VASOS SANGU\u00cdNEOS ....................................................50 ....................................................49 GRUPO ABO S\u00edlis ..............................................................................65 Toxoplasmosis Trypanosoma ENTRE .........................................43 SANGRE A SER USO DE DROGAS Malaria, \u00c1rea la Salud y Prevenci\u00f3n y Control de Enfermedades, Prevenci\u00f3n y Control de las Enfermedades Transmisibles. Nacido, Ni\u00f1o y Joven - Comunidad. Chessa Lutter, Asesora Regional Nacido, Ni\u00f1o y Joven - Salud Familia de la Comunidad. Rafael Mazin, Asesor Regional Ni\u00f1o y Joven la Comun idad. Lundie R. Richards, Asesor en MD, Estados olombia. LLM, MBA, Director, Marketing and Member S ervices, America's Blood Centers. Washington, D.C., Estados Unidos de Am\u00e9rica. Michael Nichol, Director, Blood Donor Services. Canadian Blood S ervices. Ottawa, Canad\u00e1. del 29 de se ptiembre al 3 de octubre del 2008 Punto 4.7 del orden del d\u00eda provisional (Esp.) 6 LA la por el VIH y otros agentes en la poblaci\u00f3n general. 2. En 1999, el Consejo Directivo de la ganizaci\u00f3n Panamericana de la resoluci\u00f3n Plan de propon\u00eda el tamizaje universal de las unidades sangu\u00edneas a fin de detectar infecciones por el VIH, los virus de la hepatitis B (VHB) y C (VHC), y la s\u00edfilis en toda la Regi\u00f3n y el T. cruzi en Am\u00e9rica Latina continental; la participaci\u00f3n universal de programas de evaluaci\u00f3n se 2005, el Consejo Directivo aprob\u00f3 la resoluci\u00f3n CD46.R5, en la a los Estados Miembros a que adoptasen el Pl an Regional de Acci\u00f3n para la Seguridad de las Transfusiones 2006-2010 y a la ora que rindiera cuentas peri\u00f3dicamente a los Cuerpos Directivos ace rca en la ejecuci\u00f3n del Plan. CD48/11 (Esp.) en Ejecutivo esfuerzos objetivo Regional de Acci\u00f3n es contribuir a la reducci\u00f3n de la mortalidad y al mejoramiento la cuatro estrategias, a saber: planificaci\u00f3n promoci\u00f3n de la donaci\u00f3n voluntaria e, la calidad Cobertura del tamizaje 6. En el 2003, 99,93% de las unidades de sangre recogidas por los observ\u00f3 tendencia de 87,17%, 86,20% y 87,06% en el 2003, el 2004 y el 2005, respectivamente (cuadro 2). 7. En el 2003 hubo 19 tamizaje todas el 2005, resp ectivamente (cuadro 3) . En el 2005, Bolivia, Para sometieron a tamizaje para el 2005%, resp ectivamente. Anguila, Belice, Dominica y Saint Kitts y y el Centro de Transfusi\u00f3n de Sevilla (cuadr 4 es apoyar on responsables de la de los programas nacionales con pa rticipaci\u00f3n de todos lo s servicios locales. No obstante, la participaci\u00f3n local participantes disminuy\u00f3 a 46,66 y 46,42 % en el 2004 y el 2005, respectivamente (cuadro 5). 9. Los voluntarios se mantuvo igual el 2005, aunque hubo una reducci\u00f3n a 33,05% en 7), se el n\u00famero real de reciben dine ro voluntarios; mientras que en el 2005, Aruba, Brasil, Colombia, Costa Rica, C uba, Curazao, Islas Caim\u00e1n, la tasa de los fue mayor s menos 50% de donaci\u00f3n voluntaria en comparaci\u00f3n con (cuadro 8). No obstante, es digno de menci\u00f3n las tasas de prevalencia de los marcadores permanecieron invariables en el gr upo de pa\u00edses mencionado primer lugar, las tasas para 8). CD48/11 (Esp.) P\u00e1gina 4 mayor y n\u00famero mayor de unidade s que no se sometieron a tamizaje en el 2004 y el m\u00e1s altos de infecciones transmitidas 2002 y el 2003, la cifra calculada de infecciones por el por a\u00f1o. cifras correspondientes en el 2004 y el 2005 fueron de 57 y 55, respectiva Latina y Caribe aument\u00f3 de 7.325.093 en el 2003 a 8.059.960 en 2005 (cuadro Las tasas correspondientes de donaci\u00f3n fueron de 121,5/10.000 habitantes en el 2003, y de 145,0/10.000 en el 2005. Hubo, sin embargo, una gr an variaci\u00f3n en las tasas de donaci\u00f3n en 12,7 La disponibilidad real de sangre a nivel na cional se ve por infecciosos entre la poblaci\u00f3n donantes de sangre, ya que las unidades de donantes en las que infeccioso 0,03% en Curazao a on una Am\u00e9rica Latina debido Las $13,4 millones. 15. En pacientes que reciben sangre. (Esp.) P\u00e1gina 5 factor determinante de la supervivencia de los pacientes. 18. El riesgo recibir de falta de laboratori o aument\u00f3 de 1 por 41.858 donaciones en el 2003 a 1 por 11.784 donaciones 2005 una transfusi\u00f3n T. cruzi era de 1 por 3.377 donaciones en el 2005, que es similar al riesgo observado en el 2003 (1 por 3.330 de 42.771 y 3.738.580 unidades de sangre en el 2005, hay una gr variaci\u00f3n en la cifra 761 Argentina hasta 10.320 en grupo de pa\u00edses con 11). 20. En Am\u00e9rica Latina, el 2005, 603.950 gl\u00f3bulos rojos a su una entre 114 y 22.155 el 2005, la tasa de donantes diferidos vari\u00f3 entre 0 y 53 %, El los ocho (cuadro 12). La mediana de la tasa de de sangre en el grupo de a 118,9) en el segundo gr upo. La mediana de la proporci\u00f3n de unidades de 0,03 a prim er grupo y de 4,09% (intervalo de 0,40 a 10,25%) en sangre voluntarios, se encuentran en el primer grupo. 22. En Caribe, se calcula que 6.425 unidades fecha de vencimiento y se desecharon en el 2005, lo que represent\u00f3 una p\u00e9rdida de La mediana de 12). Plan Regional de Acci\u00f3n para la Se emas nacionales de sangre. Argentina, Colombia, Costa Rica, Ecuador, Salvador , Guatemala, Guyana, Hait\u00ed, Jamaica, M\u00e9xico, o el Solo Paraguay relativa la sistemas onales esos c\u00e1lculos. Argentina, Bahamas, Colombia, Costa Ri ca, El Salvador, Granada, Guatemala, Islas V\u00edrgenes Brit\u00e1nicas, y que variables geogr\u00e1ficas temporales. Considerando la de sangre de Aruba, Suriname iniciado la Belice, Bolivia , Costa Curazao, Ecuador, El Salvador, Guyana, Hait\u00ed, Jamaica, M\u00e9xico, Nicaragua y Paraguay ya prepararon sus Belice, Costa han im plantado sistemas de hemovigilancia. Colombia, Cuba, Curazao y Nicaragua Paraguay un sistema el se logr\u00f3 un avance considerable en materia de seguridad de en la Regi\u00f3n de las Am\u00e9ricas (cuadros 1-3, 7, 9 y algunos pa \u00edses manera, la Regi\u00f3n aument\u00f3 de 15% en donantes de sa ngre voluntarios, la proporci\u00f3n los y pone necesidad de lograr don aci\u00f3n repetida, voluntar ia 8 27. \u00f3n Panamericana de la Salud en los pa\u00edses es factor importante. 28. Los planes de trabajo regionales aprobados por el Consejo Directivo en 1999 y en el 2005 incluyeron el logro de la meta de 50% de pacientes que por los servicios de sangre, el sangre en esta blecimientos de administrativos recuperaci\u00f3n co de funciona como las competencias la Seguridad de las Transfusiones sus sistemas nacionales de sangre en el marco de la Agenda de Salud para las 33. Se recomienda que ministerios de la supervisi\u00f3n y el funcionamiento general seguridad ministerios de los componentes sangu\u00edneos, 2) no selecci\u00f3n la captaci\u00f3n de los donantes y de la obtenci\u00f3n de la sangre debe ser ral y de adultos mayores, b) la inclusi\u00f3n social de las poblaciones c) por accidentes (Esp.) P\u00e1gina 10 programa reposici\u00f3n y las remuneradas antes del final de l 2010, con la meta de alcanzar el 100% en de los Am\u00e9rica Latina y el Caribe. 40. Debe red el costo obtenci\u00f3n y pr ocesamiento de las unidades sangu\u00ed neas, el nivel diario de la cobertura de necesidad calcu lada de sangre y la repercusi \u00f3n de las transfusiones en el bienestar de los pacientes. 42. Los s de de las gu\u00edas de tr ansfusi\u00f3n en los hospitales. 43. Las oficinas de la OPS en los pa\u00edses de ben tener dedicado especialmente a coordinar sanitarias y y seguridad de la informaci\u00f3n se en este documento y su sometidas a tamizaje en la Regi\u00f3n entre el 2000 y el 2005 2000 2003 2004 2005 Unidades recogidas (N) 6 409 596 7 325 093 7 559 080 8 059 960 para 7 315 191 (99,86) 7 460 221 7 011 313 335 7 383 987 (97,68) 7 900 040 (98,02) Am\u00e9rica Latina entre el 2000 y el 2005 2000 2003 2004 2005 Unidades para tamizaje (N) 5 700 259 7 097 339 6 888 289 7 419 274 Unidades sometidas a tamizaje 4 502 114 (78,98) 6 251 932 (88, 09) 5 938 183 (86,20) 6 459 612 (87,06) pa\u00edses que notificaron tamizaje universal entre el 2000 y el 2005 2000 transfusi\u00f3n entre el 2000 y el 2005 2000 2003 2004 2005 N\u00famero de pa\u00edses latinoamericanos 18 18 18 18 N\u00famero de pa\u00edses del Caribe 0 18 20 20 N\u00famero de bancos de sangre latinoamericanos 20 20 20 21 N\u00famero de bancos de sangre del Caribe 0 22 21 24 CD48/11 (Esp.) Anexo A - 2 - Cuadro 5: N\u00famero de participantes infecciones transmitidas por transfusi\u00f3n entre el 2000 y el 2005 2000 2003 2004 2005 N\u00famero de bancos de sangre en Am\u00e9rica Latina 4 738 2 509 071 2 546 N\u00famero de bancos de sangre participantes 1 129 1 330 1 433 182 de participaci\u00f3n 23,82 53.01 Cuadro inmunohematolog\u00eda en Am\u00e9rica Latina y el Caribe entre el 2000 y el 2005 2000 2003 2004 2005 Am\u00e9rica Latina 24 30 29 48 Caribe 0 24 24 24 Cuadro 7: N\u00famero y porcentaje de donantes voluntarios y remunerados entre el 2000 y el 2005 2000 2003 2004 2005 Unidades recogidas (N) 6 409 596 7 325 093 7 559 080 8 059 960 Donantes voluntarios (N) (%) 989 885 (15,44) 2 641 739 498 174 (33,05) 2 018 (36,60) Donantes remunerados (N) (%) 31 725 (0,50) el 2000 y el 2005 Marcador Pa\u00edses con 2000 2003 2004 2005 < 50% de de los indicadores de seguridad de la sangre entre el 2000 y el 2005 Variable 2000 2003 2004 2005 Infecciones por el VIH transfundidas (N) 30 6 193 2 374 2 362 Riesgo de T. de la sangre entre el 2000 y el 2005 2000 2003 2004 2005 N\u00famero de unidades recogidas 6 409 596 7 325 093 7 559 080 8 059 41. 858 1: 9. 817 1: 11. 784 Riesgo de transfusi\u00f3n de T. cruzi 1: 762 1: 3. 340 1: 3. 150 1: 3 .377 Cuadro 11: Eficiencia de los sistemas nacion ales de sangre en Am\u00e9rica Latina, 2005 Grupo 1 Grupo 2 Grupo 3 Variable Argentina Rep\u00fablica Dominicana Uruguay Venezuela Guatemala Panam\u00e1 Per\u00fa Bolivia Nicaragua Chile Honduras M\u00e9xico El Salvador Costa Rica Paraguay Colombia Ecuador Brasil Cuba Media de unidades recogidas por banco de sangre 1.404 2.334 los sistemas nacionales de donantes (%) ITT Tasa de unidades desechadas (%) St. Kitts y 6,85 Islas Caim\u00e1n 10 0,11 20,0 Grupo y las Granadinas 20 6,68 12,7 Oficin a Regional orden del d\u00eda: Mejoramiento de la disponibilid ad de sang re y la seguridad de las transfusiones en las Am\u00e9ricas Scheme del Reino Unido; Internatio nal Consortium Cruz Roja y de la Media Luna Roja, Ginebra; International Society for Blood Trans fusion, delegaci\u00f3n regional de Caracas (Venezuela); Internatio Rotary Estad Unidos, El Salvador, Colombia, Ecua dor, Chile, Uruguay, Paragua y, Santa Lucia , las Islas Salud, Instituto Nacional de Vigilancia de amentos y Alexandra Hospital, Anguila; Hospital, Bahamas; Service, Belice; Peebles Hospi tal Hospital, Dom inica; ada; National Blood Transfusion na; Natio nal Blood Transfusion Service, Jama ica; Joseph N. France General Hospital, Saint Kitts; Blood Bank Service, Santa Luc\u00eda; Milton Cato Memor ial Hospital, San Vicente; Natio nal Blood Bank, Suriname; Natio nal Blood Transfusion Service, Trinidad y Taba go. 6. V\u00ednculo entre este punto del orden del los pa\u00edses de las Am\u00e9ricas con CD48/11 (Esp.) Anexo B- 2 - la participaci\u00f3n de los centros colaboradores de la OPS y las fuerte del ministerio de salud. Los p\u00e1rrafos 26, 28, 29, 30, 32, 33 y 38 del documento CE142/20 hacen referencia otras infeccion es. Los p\u00e1rrafos 5 a 8, 10 a 17, 23, 28, 33 y 36, y los cuadros 1 a 5 hacen referencia a estos de de las es s y dentro de ellos de los pa\u00edses y ellos. 2006-2010 el equitativo gracias a una mayor inclusi\u00f3n social. Los cuadr os 10 a 13 y los p\u00e1rra fos 12, 13, 14, 34, 35, 36 y 40 abordan la protecci\u00f3n social y el acceso a sistemas nacionales de sangre en el marco de la Agenda de Salud para las Am\u00e9ricas 2008-2017.30 a Panameric ana para de a 48 millones Los p\u00e1rrafos 13, 19 y 21 refere EUA, el se resumen las dificultades observa das en la ejecuci\u00f3n de l plan regional acci\u00f3n para y Teniendo resumen las dificultades observa das en la ejecuci\u00f3n de l plan regional acci\u00f3n para en la atenci\u00f3n m\u00e9dica apropiada de los pacientes y en la re ducci\u00f3n de la mortalidad de las madres, los lactantes, negativos y CD46.R5 (2005) a\u00fan son vigentes en la Regi\u00f3n de que las autoridades nacionales aplicar por Miembros: a) a que decididamente el plan regional para la supervisi\u00f3n eficaz de excluidas, de voluntarios que ayude a educar la comunidad, programas pongan fin a la donaci\u00f3n de sangre re munerada y de reposici\u00f3n antes la sangre no es responsabilidad s\u00f3lo de los m\u00e9dicos en intercambien las pr\u00e1ct icas \u00f3ptimas en relaci\u00f3n c de los donantes voluntarios. 2. Solicitar la Directora: que coopere con los Estados Miembros en la ejecuci\u00f3n del plan regional de acci\u00f3n educaci\u00f3n p\u00fablico, derec hos humanos y de los la garant\u00eda de la calidad la eficiencia financiera; que en del 29 de se ptiembre al 3 de octubre del 2008 CD48/11 de Del costo estimado que se indica en el apartado b, en del 29 de septiembre al 3 de SEGURIDAD DE LAS TRANSFUSIONES sangre en que se la la atenci\u00f3n m\u00e9dica apropiada de los pacientes y en la re ducci\u00f3n de la mortalidad de las madres, los lactantes, negativos 2 por RESUELVE: los tome la supervisi\u00f3n eficaz educar la comunidad, para la sangre no es responsabilidad s\u00f3lo de los m\u00e9dicos en los hospitales; c) a que pongan fin a la reposici\u00f3n obligatoria de sangre por parte del paciente para d) a que intercambien las \u00f3ptimas en relaci\u00f3n donantes CD48.R7 (Esp.) 3 2. que coopere con los Estados Miembros en la ejecuci\u00f3n del plan educaci\u00f3n p\u00fablico, derec hos humanos y de los la garant\u00eda de la calidad la eficiencia financiera; en la Regi\u00f3n. (S\u00e9ptima reuni\u00f3n, 2 de octubre del 2008) "}